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1. INTRODUCTION AND AIM OF DIPLOMA THESIS 
The health system in Greece is an area of friction and controversy for many 
years. Amid economic crisis, medical prescriptions, a major change was held, in order 
to organize, manage and reduce the chronic wasting, observed in reserves of pension 
funds. In general, attempts to summarize the existing operational framework. 
        This thesis is working on the issue of medical prescriptions in Greece. The 
introductory chapters are describing the historical overview and introduction of the 
social security system in Greece. It is also describes the historical evolution, the current 
structure and the main possibilities and disadvantages of the greek health system. Then 
it describes the main social security institutions and their characteristics. The legal 
status of prescription and general legal regime define the duties of health professionals 
and is described through presidential decrees and Greek law. In this thesis is given great 
importance to the Law concerning drug trafficking formulations as well as the 
fundamentals of ethics of the medical and pharmaceutical profession. The electronic 
prescribing is applied for many years in many Western countries. Plus, it is a modern 
achievement of contemporary Greek reality came after reactions of professional 
disciplines from many difficulties. 
The aim of diploma thesis is to get current knowledge about medical 
prescriptions in Greece and rules of their use, to demonstrate their basic division 
according their kinds, formal look, practical handle with them and their payment and 
finally to gather samples of medical prescriptions. The secondary aim of this diploma 
thesis is to explain and describe the main characteristics of the greek health system, in 
order to support the general knowledge around way of dispensing and compensation of 





2. HEALTH SYSTEMS IN GENERAL AND IN GREECE 
The following chapter describes the institutional framework, process, content, 
and implementation of health and health system in Greece. Also look at reforms in 
progress or under development and make an assessment of the health system based on 
stated objectives and outcomes with respect to various dimensions. 
2.1 HEALTH SYSTEMS GENERAL APPROACH 
2.1.1 GENERAL THEORY OF SYSTEMS 
Theoretically, the term “system” refers to a set of components which are 
connected together. We could also define the system as a sum of independent parts, 
linked together in such a way as to create an integrated whole, able to perform a 
function. Today this concept is becoming less and less important and gaining ground in 
the systemic approach, namely that the system is the sum of the individual subsystems, 
but it is a whole, which has its own function. Liaropoulos [15] defines the system in a 
similar manner. He considers that the system is any group of interrelated and 
interdependent entities or processes that combine for a particular purpose. The key 
feature of this definition is the parallel operation of entities and processes. A more 
specific definition of the system considers the system as a whole and given a defined 
behavior, which consists of elements that are in a dynamic interdependence between 
them. As described by the systemic theory, we can define the notion of "system" based 
on the following data – assumptions [29]: 
 The system is not just the sum of its parts 
 the elements are in constant and dynamic interdependence between them, but in 
interaction with the environment 
 the system as a whole, as individual items - subsets, operate in such a way as to 
fulfill their reason for being and the purpose for which they were created 
 
 All systems have certain key feature, such as [29]: 
 between the system and environment, relationship interaction and 
interdependence are developed 




 between system and environment, there is a constant exchange of information 
 complexity of a system depends mainly on the amount of data that includes the 
relationships developed between the elements 
 each system differs from the hierarchical structure that governs 
 every system has a specific purpose and specific objectives to be achieved 
 A detailed analysis of the system’s behavior 
 determine its ability to meet its objectives and to make changes depending on 
environmental conditions 
 
2.1.2 HEALTH SYSTEMS 
Based on what we was analyzed previously, one can define the health system as 
a set of subsystems that are in constant interaction with each other and with the 
environment in order to achieve the purpose of the system is to maintain and promote 
health. We also define the health system as a specific mode of organization and 
management of human and material resources of the health sector, which through the 
planned development of services aimed at maximizing the level of health of the 
population in the economic potential of society. According to Kalogeropoulou and 
Mourdoukouta [6], the health system of multiple subsystems that are in constant 
interaction and interdependence between them. An alternative approach is to assume 
that the first subsystem relates to the financing of health, the second subsystem 
associated with the logistics of the system, subsystem refers to the third generation of 
health services and goods. Also we can assume that the first subsystem concerned with 
primary health care, the second subsystem referred to secondary health care and the 
third sector reported higher health care. According to Soulis [29] the health system can 
be defined in three ways: 
 Health Systems multivariate 
 Health Systems total turnover 
 Health Systems as a production process 
 




 Mechanism investigation of factors affecting the health status of the population 
 Mechanisms of production and distribution of goods and services, health 
 Mechanism for the costs of health 
The second aspect of the health system as turnover believes that the health 
system consists of nine modules turnover [29]: 
 Subsystem medical circle. Includes classic primary and secondary care, such as 
health centers, rural hospitals, private clinics, pharmacies, dentists, the 
ambulance  
 Subsystem medical-social circle 
 Subsystem domain environment. Care to ensure public health, hygiene and 
safety at work, environmental hygiene and school hygiene 
 Subsystem alternative forms of care. Nursing home, support counseling center 
for AIDS, for battered women 
 Subsystem research centers. Includes research units dealing purely with the 
health sector, such as Cancer Institute. 
 Subsystem alternative medicine. Includes homeopathic centers, clinics 
acupuncture centers osteopathology etc. 
 Subsystem production. Includes plants bio-medical engineering, medical 
materials, consumables etc. 
 Subsystem secondary production. Is not primarily the task of producing health 
services, and health professionals use to offer health services in salons, dietetics, 
physical centers etc. 
Finally, the third aspect of the health system as a production process considers the 
health system as a standard production model that includes [15]: 
 Inputs. It is the human resources, physical infrastructure, technological 
equipment, etc. 
 Process, used to produce health services, such as doctor visits, exams, etc. 
 Outputs, as the result of the production process is measured by days of 




 Results, in order to improve the level of health and quality of life. 
2.2 HEALTH SYSTEM IN GREECE 
2.2.1 HISTORY 
Greece faces one of the biggest problems worldwide, a deficit that is transmitted 
from generation to generation. The lock according to studies is a key factor in 
increasing the deficit. If not handled with bravery and prudence, the margins for growth 
and competitiveness of the economy are shrinking, especially in the reality of 
globalization. Such an evolution leads mathematically to the recession, unemployment 
and the deterioration of living standards. 
Early on, Greece's social security system resembled the German one (Bismarck). 
Subsidiary insurance appears in 1861 with the establishment of equity funds the Army 
and Navy and Pension Fund Civil Employees (ANPFCE). The supplementary pension 
covers gaps of the primary insurance and offers benefits to freelancers and employees. 
Its main feature is that it relates to specific classes of insurance and provides specific 
invalidity and death. The first insurance fund created is ANPFCE. Most funds were 
raised in the coming years regarding the coverage of people from accidents, illness and 
old age. Through the period of 1914-1933, the main funding sources of those funds 
were the contributions of workers and employers. [3] 
The first serious attempt to formulate an insurance policy health appeared in the 
early 30’s. After great social pressures and intense political controversy, the dictator 
Metaxas was forced to pass Law 6298/1934, which created the Social Insurance 
Institute (IKA) for employed workers and private sector employees. IKA began 
operating three years later (1937) due to economic problems and covered the risks of 
disease, old age and unemployment of the workers in urban centers. In 1961 he passed 
Law 4169/1961, according to which the Agricultural Insurance Organization (OGA) 
was created, in order to cover the rural population. Its main purpose was to grant 
pension benefits to old age people and widows and provide medical care to the rural 
population of the country. [15] 
 
2.2.2 CURRENT GREEK HEALTH SYSTEM 
The Greek Healthcare System (GHS) is characterized as a mixed one. Primarily 




part of its funding comes from insurance contributions and another party, especially at 
the level of hospital care, from taxation. Also there is an increasing involvement of the 
private sector in both the provision and the financing of health services. The Greek 
Healthcare System (GHS) was founded in 1983 and aimed at general health care 
reform. Its main objectives were equitable provision and financing of health services 
with complete coverage of the population, the development of primary health care, 
decentralization of planning and improving the organization of health services [4]. 
The Ministry of Health and Welfare (MHW) is primarily responsible for the 
development of health policies in Greece. The financing of the health system is through 
a mixed system. The main resources are general taxation and social insurance and 
private spending. Private expenditure on health amounted to approximately 43 % of 
total expenditure on health. Primary care is provided by hospitals, health centers and 
insurers [25]. The services of hospitals and health centers funded by the state budget and 
the employees are paid a salary while in the case of employees in insurance funds, they 
are paid by the Fund itself. The key features of the GHS [6]: 
 mixed system 
 he funding system is funded through general taxation and social security 
 The Ministry of Health and Welfare is primarily responsible for the development 
of health policies in Greece 
 health services within the GHS administrative regions (DYPE) 
 primary care is provided by insurance carriers, from outpatient hospitals, private 
practitioners and health centers 
 secondary care is provided by hospitals 
 fees are hospital doctor’s salary or a private medical service 
 
The main advantages of the GHS are [19]: 
 equitable provision and financing of health services 
 complete coverage of the population 
 emphasis on hospital care 
 limited citizen participation in the cost 
 development of health education programs 
 




 high health costs 
 underdeveloped primary care 
 limited freedom of choice of doctor by patients 
 problems of geographical and economic disparities, fragmentation and lack of 
coordination bodies 
 informal payments, problems of moral medical practice, many doctors and other 
health professionals shortage and patient waiting lists 
 
The fact that Greece is going through a prolonged period in which the rights and 
achievements of workers and compressed welfare state shrinks. Timeless for historical 
and politicians was a significant delay in securing and developing institutions with a 
social content impact the state interventionism and living standards of the population. 
The main characteristics of the Greek pension system is complexity and a wide variety 
of provided services. It is a mixed system with elements from both classical protection 
systems Beveridge and Bismarck, vulnerable to fluctuations with all relevant 
consequences [3]. The causes are divided into intrinsic and extrinsic and in which 
included demographic, unemployment, economic recession, large number of actors, 
contribution evasion, the complexity of Law, lack of automation, favorable regulations, 
age limits etc. The reason why the insurance problem remains unresolved is that at the 
same, it is deeply structural. The system in organizational form and the sectoral 
dimension resembles a private funded scheme and its funding of is distributive. 
Features professional and public universal insurance systems coexist with sectoral 
fragmentation entities that do not allow the operation of the principle of solidarity with 
which conflicts with the principle of reciprocity and does not allow state aid and any 
participation at state to those categories of the population who have the greatest needs 
while it cannot be fought and contribution evasion only policing and converting insurers 
to services police structure and function. 
The current system is plagued by [25]: 
I. Legislative complexity involved and opacity in expansion injustice: Greek 
workers contribute for themselves, years of service and same wages, taking 
different pensions 
II. Fragmentation and waste: The system is fragmented into individual groups. 




industries and because not made by experts. The monitored and inspected in 
accordance with uniform rules are extremely difficult. It is impossible to achieve 
economies of scale. 
III. Lack of reciprocity: Contributions are not associated with benefits. The 
contributions cover the minimum pension benefits, replenishing social 
protection. The social policy exercised by governments at the expense of funds. 
The branches are often supported by health pension reserves, thus eliminating 
further the concept of return. 
IV. Disorganization: Due to fragmentation, excessive Law and complexity, the 
system as a whole cannot be recorded with a single accounting system and 
computerized way. It is noteworthy that the insured population of the country 
operate 171 supervised funds. The Greek society receives a fair share of 
technological development and economic progress. It is normal practice, with a 
tolerance of policy-holders, insurance-declared earnings will often represent a 
subset of the real. This option is often conscious of by workers due to lack of 
reciprocity and because for drafting counted only five rather than entire career 
[21]. 
 
In conclusion, the Greek healthcare system has significant problems that 
jeopardize its own personality and the needs of the population to health services. The 
Greek health system must address three major problems. The first problem relates to the 
economic - financial system. The second problem relates to the effective operation of 
the third problem relates to the satisfaction of the average Greek of health services [31]. 
The method of billing of hospital services (less than the actual cost), the hospital 
overpriced markets and other material wastage in the health system, the decrease in 
revenue due to evasion and undeclared work have resulted in budget deficits in the area 
of health. It is necessary for the system to achieve financial viability, because otherwise 
threaten the survival of the system and the health services. The second problem facing 
the system is ineffective. Not facilitate equal access of citizens to the health system and 
the cost of providing health services is higher than it should be because of the inflated 
bureaucracy. The third problem relates to the Greek citizen satisfaction from health 





2.2.3 INSURANCE FUNDS 
It is a fact that the Greek Social Insurance Scheme is among the most generous 
pension systems in the world, as indicated in research studies, such as the one that 
Finance Alpha Bank titled, "Funding Social Security - The Role of the State pension 
system". 
The average actual retirement age nowadays formed below 60 years where 
office workers in 58 years, employed in services and sellers to 58.9 years, in the Armed 
Forces 54.3 years, technologists - technical assistants in 56.9 years, while retirement at 
65 was a rather unusual situation [19]. Under investigation by the NSSG in May year 
2006, the average number of years of work stands at 31.5 years, while for graduates of 
higher education does not exceed 28.7 years. Moreover, the number of early retirement 
on grounds of disability, minor children, sailors, heavy and arduous professions, 
without the necessary financial coverage insurance systems are generally much higher 
in Greece than in other countries [26]. 
The replacement rates of pensions in Greece is among the highest in the world 
and the greatest importance that formed at the same high level for all pensioners 
regardless of the amount of income before retirement, unlike most OECD countries 
where the high income replacement rate is very low. The imbalance caused by high 
rates of replacement and the relatively early retirement from politics compounded 
increase of pensions, for all income levels at rates higher than those salaries, which 
usually exceed and increase GDP [32]. This policy not only leads to a further increase in 
replacement rates than the already high levels prevailing during the initial payment of 
pensions. Also in connection with the tendency for a greater increase in the number of 
pensioners relative to the increase in the number of employees, it contributes to further 
destabilization of the system. It should also be noted here that any reform of the pension 
system should take into account the following considerations for pension levels 
nowadays, as follows [19]: 
 The National Social Insurance Scheme should be based on private savings, 
which should promote and complement the state budget to provide adequate 
minimum pension to all elderly 
 For workers in high-income or whose funds are supported today in financing 
from the state budget, their pensions will be determined by the amount of their 




based one average life expectancy after retirement without effective 
interconnection of benefits to contributions, the imposition of necessary 
mandatory of pension savings is virtually impossible. For example, tax evasion 
plaguing the General Discussion, we will not be overcome by establishing a 
system for identifying related pension contributions [32]. 
 One should consider more carefully the potential impact of the application of 
state-controlled pension programs - especially those with limited tax-benefit 
linkage behavior of the insured therein. Has been observed in many countries, 
especially in Greece, the implementation of such programs leads to surge in 
early retirement with pensions too high and results in a dramatic reduction in the 
percentage of workers in the total population aged 52-64 years, adding 
substantially large problem viability of insurance schemes because of the 
tendency of the aging population [32]. 
 The compulsory nature of pension savings does not require a state-controlled 
pension funds. Instead, the funds may belong to the insured provided they are 
well organized and ensure effective management of the retirement savings of 
their members. The state sets the rules for the operation and control of these 
funds with the primary objective of protecting pension assets of insured and 
guaranteed pensions [2]. 
 
The four bigger insurance funds are described below. Their main characteristics 
and information about their previous and current situation are given as well.  
 
SOCIAL INSURANCE INSTITUTION (IKA)  
The overall primary insurance carrier for employees is the Foundation Social 
Insurance, which was founded in 1934 and began to operate substantially in the decade 
of 1950. In 1958, IKA expanded the insurance coverage of private sector workers from 
across the population, thus broadening the protection afforded before the foundation of 
specific categories of workers through special main insurance funds employed, but also 
covering employees without insurance. Several special funds still operate today 
independently under the supervision of the Ministry of Labor and Social Insurance and 
some merged with IKA. IKA insure people, whose main occupation is to provide 




newsagents, writers, apprenticeship. Risks covered include maternity, family 
responsibilities, illness, old age, disability, death, accident and occupational disease, and 
unemployment [6]. 
Those insured by IKA have the advantage to enlist to the Manpower 
Employment Organization (OAED), in case of unemployment, which was founded in 
1954 and is supervised by the Ministry of Labor and Social Insurance. OAED also 
covers conscription risks and family responsibilities of employees. Social benefits in the 
form of housing programs, social tourism recreation are also provided to the insured by 
IKA. The special primary insurance funds cover specific categories of workers, not 
covered by IKA. Prerequisite eligible for insurance of these funds is to provide indirect 
employment or the pursuit of a specific occupational specialty. The auxiliary cover of 
the private sector workers, is provided by a number of associations of public and private 
law, grant additional retirement benefits, in the form of a monthly pension or single 
device [21]. 
 
AGRICULTURAL INSURANCE AGENCY (OGA) 
Insurance protection for farmers is considered one of the main axes of the Greek 
social security system due to its particular development of the primary sector in the 
country and the increased contribution farmers in Greece's economy. Farmers covered 
by one self-insurer, the Agricultural Insurance Organization which operates as a legal 
entity under public law. OGA was founded in 1961 by Law 4169/1961, seeking cover 
specific risk insurance for individuals employed personally by main occupation of the 
rural economy. The Agency also covers specific categories of farmers and persons 
equated with farmers in order to acquire insurance protection. It insurance scheme for 
farmers is divided into three periods. 
The first period (1961-1981) refers to the creation and development mechanisms 
of insurance protection to farmers through OGA operation, which covered the risks of 
disease, old age, disability and death. The Agency granted non-contributory benefits to 
policyholders, since despite legislative provision for the payment of the relevant 
arrangements not activated before. The Agency also granted compensation to owners or 
exploitative agribusiness in case of damage to production due natural disasters (hail, 
frost, etc.). The second period (1982-1995) provide insurance protection farmers, 




institution of additional security for farmers. Law 1745/1987 [13] establishes a special 
separate and additional mandatory insurance industry of farmers, who gives 
contributory benefits in the form of additional pensions to members of OGA in old age. 
The main features of the new insurance scheme farmers is describes as followed [4]: 
 The funding of pension benefits from the contributions of insured (contributions 
calculated at the rate of 7 % on amounts seven different insurance categories, in 
which insured classified after their relative statement) standardization of state 
funding to OGA (the percentage of state levy is set at 14 % on amounts seven 
insurance categories) 
 The introduction of successive insurance for their farmers (i.e. the years carried 
insurance in case integration in new insurance scheme from another 
organization) 
 The introduction of an automatic increase of pensions, which corresponds to the 
rate of indexation officials 
 Extension of sickness benefits in kind for insured OGA pensioners and members 
of their family (For even the possibility of service of persons and those from the 
health services IKA) 
 The sickness fund by contributions insured (contributions estimated at 1.5 % on 
amounts of seven different insurance categories, which insured classified after 
their relative statement) 
 The establishment of a pension due to death in the same conditions (non-
retirement, non-employment in another job other than those covered by OGA) in 
both the widow and the widow the introduction of thresholds for pensions and 
disability off work due to an accident (but there are no minimum limits for 
retirement pensions). 
 The new insurance scheme for farmers allow integrated coverage of the rural 
population through a modern system protection that would ensure the medium 
level convergence benefits with their respective employees. The system is now 
based on established principles of social insurance (redistribution, reciprocity) 
and strengthened by the provision of state participation in financing. It also 




policyholders and pensioners through OGA Account Rural Outbreak was 
established in 2002 and operates under the OGA [19] 
 
OFFUND OF INDEPENDENT EMPLOYEES (ETAA) 
The free and independent professionals are covered by separate social security 
agencies operating in the form of legal person public law. In 2002 there were five main 
actor's insurance professionals and three main insurance independent professionals. 
The main insurer of professionals is Freelance Security Agency (OAEE) 
established the 1999, covering mandatory persons practicing the profession of trader, 
the artisan, the motorist and hotelier. The OAEE operates as a legal entity of public law 
and that p have merged three entities covered before the establishment of specific 
categories of skilled professionals, the Insurance Fund Dealers (ICF), the Fund 
Professionals and Craftsmen Association (TEVE) and Motorist Pension Fund (TSA). 
From an organizational perspective, includes two branches, the pension sector and the 
health sector, which have complete financial and accounting autonomy 65. The OAEE 
provides insurance coverage for free professionals in old age, disability, death, accident, 
sickness and maternity. It also provides coverage of members of families of the insured 
in case of illness or death [24]. 
The vectors represent the main independent insurance professionals, which is 
the Lawyers' Fund, the Pension Fund self-insurance Health (TSAY) and the Pension 
Fund Engineers and Contractors (TSMEDE). The Lawyers' Fund covering lawyers, 
notaries, bailiffs and certain categories judges. The TSAY cover those who practice the 
professions of doctor, dentists, veterinarians and pharmacists. TSMEDE covers 
qualified civil engineers, mechanical engineers, electricians and those who practice the 
profession of public contractors [19]. 
 
CARE INSURANCE AGENCY FOR PUBLIC (ΟPΑD) 
The security of public employees is covered by the main actors and 
supplementary insurance companies supervised by the Ministry of Labor and Social 
Security, the Ministry of Defense and Ministry Finance. Primary insurance carrier is the 
Public sector, covering civil servants insured through the state budget. The auxiliary and 




bodies supplementary grant pension and lump sum payment to persons falling within 
their scope. By 1999 there were twelve Public Relief Funds Employees, the Insurance 
Fund and Public Municipal Employees, the Insurance Fund Organizations Social 
Insurance, the Employees Provident Fund and the Pension Fund Policy Employees, 
which covered all regular civil servants. In 1999 it was decided to consolidate the 
twelve Relief Funds to ensure a greater administrative and financial flexibility and 
effectiveness of the system of public insurance subsidiary employees. So from 1.4.1999 
a new body called 'Auxiliary Pension Fund of Public Employees which is supervised by 
the Ministry of Labour and Social Insurance [15]. 
 
2.2.4 CURRENT GREEK PENSION SYSTEM 
Since a big amount of greek population that has continuing access to the prescribing 
system of the country in monthly basis are the people of third age and mostly the 
pensioners, it is considered reasonable and necessary to understand who the greek 
pension system works. 
The Greek pension system, like those of Europe, is public and redistributive. 
The system shows solidarity between generations, while each one undertakes to pay the 
pensions of the former. This insurance system ensures social cohesion and combating 
exclusion through participation in the development of economy. In this sense, the long-
term actuarial balance system is a key component of development. Unlike threats 
balance was undermined growth medium [24]. The key question that often arises is 
whether the current retirement system responds to what extent the above. The following 
are worth highlighted: 
 Although spent over 12 % of GDP pensions (10.5 % average in OECD 
countries) old age associated with a higher risk of poverty. 
 The resources paid for by public insurance system budget year exceed 3 % of 
GDP, but other 1 % paid under Law 3029/02 in IKA, the others are not 
institutionalized. 
 Existing over-regulation and unequal treatment of similar cases weaken the 
social acceptance of the system. Simultaneously leads to significant operating 




 Continued threats for further changes without providing convincing answers to 
the problem, have strengthened the feeling Liquidity and insecurity among 
citizens and tough any initiative even marginal changes. 
 
The Greek pension system therefore continues to have some inherent 
weaknesses that exist even before the starting act, on the future challenges 
(globalization, aging population, demographic, etc.) [1].The shortfall of contributions is 
presented in pension funds by the following [19]: 
 The fact that the government persists in failing to pay the entire Grant has 
established itself. Current debts to public pension funds amounted to 8.7 billion 
€, while the state often exempts itself from contributions. 
 The vast extent of evasion because of the black and working uninsured. The 
uninsured work in our country surpasses the 1 million while 1 in 4 persons and 1 
in 7 Companies do not exist for the IKA. 
 The vast expanse of uninsured in many categories workers. For example, in 
2005 9.1 % of insured IKA had average monthly wage to 100 €, 18.6 % had 
101-300 € and 16.7 % had 301-500 €. 
 Practice within the government to recruit uninsured employees. Contracts stage, 
that are currently growing form of employment in the public, do not 
 Huge employer contribution evasion that only touches the IKA 3 billion 
drachmas fact that 33 % of these debts are insurance contributions that have 
paid employees to employers. Dozens are favorable arrangements for the non-
performance of all money paid by employers and the legal tax exemptions for 
so-called development reasons [25] 
 
3. LEGAL STATUS OF HEALTH SYSTEM 
3.1 INDEPENDENCE AND MEDICAL ETHICS 
The primary concepts, definitions and scope of medical ethics are described in 
Law 3418/1985 from the Code of Medical Ethics as follows [20]: 
1. Medical practice that has as its objective by any scientific method prevention, 




2. As medical practices are those that have research character as designed and 
more accurate diagnosis, rehabilitation or improvement of human health and the 
promotion of science. 
3. The concept of medical practice including prescribing, the command to perform 
any kind of para-clinical examinations, issuing licenses and medical certificates 
and general counseling of the patient. 
4. The term "patient" includes any user of health services, whereas the term 
"familiar" include relatives by blood and marriage in a straight line, adoptive 
parents and adopted children, spouses, permanent companions, brothers, spouses 
and permanent partners, legal guardians or curators of the patient and those who 
are under guardianship. 
5. The provisions of this apply to the exercise of the medical profession and 
service charges primary, secondary or tertiary health care in the public or private 
sector, regardless of the mode or form of exercise of the medical profession, 
individually, in groups or as medicine company as a profession or not. 
 
On the other hand the general rules, governing the medical ethics are described 
in Article 2 [20]. Specifically, the practice of medicine as a vocation: 
1. The practice of medicine is a ministry that seeks to de-preservation, 
enhancement and restoration of physical, spiritual and mental health of man, and 
to his relief from pain. 
2. The doctor observes the oath of Hippocrates, performs its task in accordance 
with applicable law and must, in the exercise of his profession, to avoid any act 
or omission which may harm the honor and dignity of the doctor and undermine 
the faith the public in the medical profession. He also maintains a high level of 
professional conduct that honors the conscience of society and promote the 
prestige and credibility of the medical profession. The doctor must demonstrate 
this behavior not only during the exercise of his profession, but in the general 
social facet of his personality. 
3. The medical office is exercised in accordance with generally accepted and 




and human dignity and is open to all people without distinction of sex, race, 
religion, nationality, age, sexual orientation, social status or political ideology. 
4. The doctor respects human life even under threat and does not use his 
knowledge against the principles of humanism. It is prohibited to provide 
support to torture or other forms of degrading and inhuman treatment, whatever 
the act for which he is accused or suspect is guilty or the victim of such 
procedures, in time of peace or war. 
5. The doctor, citing reasons of conscience, has the right not to participate in 
legitimate medical procedures which opposes consciousness, except in urgent 
cases. 
6. If the clinician's judgment may be impaired by a medical condition from which 
they suffer, and if the doctor has or is a carrier of one contagious disease, should 
seek advice from a doctor or properly trained labor colleagues about the need or 
how to change provider its services. In these cases, the doctor should not be left 
to the exclusive personal assessment of the likelihood. 
 
The doctor should promote equal access to health services and equal distribution 
of resources. He also avoids the discriminatory treatment resulting from educational, 
legal, economic, social and geographical differences. He or she should work 
harmoniously with colleagues and other staff and to take any action in order to prevent 
medical errors, ensure patient’s safety, to gram minimum wastage of resources and 
maximize results for health care. The doctor must, without limiting the moral and 
scientific independence, and without losing sight of the benefit to the patient to 
prescribe and to proceed only on medical procedures that are necessary to ensure the 
quality, safety and efficiency of health - legal care or treatment provided. Finally, both 
individually and through their medical societies and associations, must contribute to the 
creation and implementation of mechanisms designed to encourage continuous quality 
improvement care provided [20]: 
Article 9 describes the obligations of the doctor to the patient, as follows [20]: 




 The doctor cannot refuse the offer of services for reasons unrelated to his 
scientific competence, unless there is a specific reason that would make it 
objectively impossible to offer its services. 
 The doctor must provide services for emergency response regardless of their 
specialty. The obligation falls on the doctor, even when there are no appropriate 
means for the practice of medicine, and is valid until the referral of the patient to 
an appropriate specialist doctor or transport to an appropriate unit of service and 
care. In each case, the doctor must exhaust the existing, under the 
circumstances, capabilities, according to the requirements of medical science. 
 The doctor may discontinue providing the services already offered to the patient, 
for scientific reasons or personal and if there is an immediate danger to the 
health or life of the latter. In this case, it must, if requested, to designate another 
colleague for his replacement. 
 The doctor must provide medical services, even without payment or 
compensation, in any event of an emergency or public disaster, regardless of 
their inclusion in a contingency reference volume. 
 
3.2 DRUG LAW 
The drug origins are described in Law 1792/1987 [8]. Drugs are natural or 
artificial substances that act in the CNS and cause dependence of the individual 
receiving it. It should be clear that the term generally refers to drug substances with 
different chemical structure and activity in the CNS by stimulating suppressor up, with 
main feature is the ability to alter the thymic status of the individual and causing mental 
or physical dependence. It is understood that the term drug are pharmacologically 
suitable for all substances as that includes substances with precisely the opposite effect, 
i.e. stimulants, has prevailed but for the needs of the legislative framework that used to 
describe natural or synthetic, with addictive substances CNS activity. Drugs are 
classified into four tables [9], as shown at table A-D of Annex 1. 
By decision of the Ministry of Health and Welfare, issued an opinion from the 
Commission on Narcotic Drugs and be published in the Government Gazette, may be 




category to another or change the terms and conditions of their disposal, in particular in 
accordance with the international conventions [8]. 
The production, possession, importation, transportation, storage, processing in 
general raw materials and finished goods imported from abroad, as and movement of 
materials and pharmaceutical products Proprietary Panel B, made by the state monopoly 
drugs  following authorization and responsibility of EOF and opinion of the 
Commission on Narcotic Drugs. The public availability of drugs in Table B as 
preparations or preparations made with special prescription drugs in quantity treatment 
of a day, which does not exceed the maximum daily dose, appearing in the Greek 
Pharmacopoeia V or determined by the Commission Drugs. The production, import, 
transport, storage and supply of substances in Table C and the finished pharmaceutical 
products and specialties containing these substances made by the state monopoly drugs 
after consulting the Commission with responsibility for Drugs EOF, who issues a permit 
and control the process. The public availability of drugs in Table C as formulations or 
preparations made with special prescription drugs in quantity treatment of a day, which 
does not exceed the maximum daily dose, appearing in the Greek Pharmacopoeia V or 
determined by the Commission Drugs. [8, 9] 
The production, import, transport, storage and supply of substances in Table D 
and the final pharmaceutical products and specialties, containing these substances made 
by individuals after consulting the Commission on Narcotic, are responsibility of EOF. 
The public availability of drugs in Table D as formulations of simple prescription drugs, 
depend on the therapeutic needs. The pharmacist needs to acquire a special license from 
the Ministry of Health and Welfare, for permission to supply drugs. According to Law 
17292/1987, pharmacies are not allowed to purchase any drug in Table A and Table B of 
the permit fee pharmacy, through the following drugs [8]: 
 Powder opium 
 Injections of morphine 15 mg or 20 mg 
 Injections of 50 mg pethidine and 100 mg 
 Sedative pills of 30 mg 





The pharmacist is obliged to keep his special or simple drug prescriptions for at 
least three years. Also is bound in a book (which takes the Management Drugs with 
drugs) at the end of each quarter, to indicate the quantity of drugs, at the beginning of 
the quarter, the amount of drugs, consumed by the sum of specific prescription drugs, 
and amount consumed for manufacture of pharmaceutical formulations [9]. 
 
3.3 LEGAL OBLIGATIONS OF UNIT HEALTH SERVICES 
The Article 7 of Law 2472/1997 [7] refers to the powers and obligations of Social 
Security regarding e-prescribing. Paragraphs 1 and 2 provide the access of Social 
Security on the basis of application for registration and electronic prescriptions both for 
the purpose of clearing them and for the purpose of monitoring the prescription 
collection and statistical evaluation of data related to benefits health and medicare. It is 
understood that access is limited to the portion of the base on each entity and not the 
entire database. For reasons of data protection of policyholders and in accordance with 
the letter and spirit of the relevant provisions explicitly states that access to health data 
is permitted only to persons engaged in the provision of professional services health and 
are bound by confidentiality or other confidential under law or code of conduct or to 
persons specifically authorized to do so and subject to a duty of confidentiality [7]. 
For the same reason, and in order to support the safety and efficient operation of 
the system, Article 3 expressly provides Social Security to take the necessary and 
appropriate technical and organizational security measures in infrastructure, IT systems 
and data. Although the commitments contracted by the social security doctors and 
pharmacists arising out of all of this configuration, Article 4 provides clarity for the 
obligation of operators to incorporate these provisions of this law on contracts awarded 
onwards either individually or collectively, with doctors and pharmacists. This section 
also points that the rules apply in all cases and for doctors and pharmacists, who have 
already signed contracts with social security until the expiration of those contracts [10]. 
 
4. MEDICAL PRESCRIPTIONS IN GREECE 
4.1 KINDS OF MEDICAL PRESCRIPTIONS 
 There are in Greece three types of prescriptions - the regular (common) and the 




detail the use, administration and distribution of the following products. Initially the 
active substances in Annex D Table 1, require a prescription with single red line and 
numbered seal, without the Prefecture or the IKA and in any quantity given by the 
doctor, e.g. 1,2,3 or 6 pieces. These prescriptions are kept in the pharmacy for 3 years, 
sealed with the seal of the pharmacy and placed in folders or binders. In Category D, 
under Law 1725/2001 decision of the Ministry of Health and Welfare, the drugs 
STILNOX, IMOVANE and SONATA were added. Conversely, drugs of table C. Law 
1729/1987, which do not contain codeine administered by monorail certified by the 
District prescription, are guarded for 3 years [13]. 
The drugs which contain codeine are granted as follows: 
 With simple prescription guarded for two years may be granted as many number 
of packages that the overall amount of codeine per prescription should not 
exceed 200 mg. 
 With prescription Law 1729/1987 (single red line - certified by the District) 
guarded for three years may be granted as many number of packages that the 
total amount of codeine per prescription should not exceed 400 mg. 
 With special prescription drugs (crossed - certified by the District) guarded for 
three years may be granted when a total number of packages, the amount of 
codeine per prescription than 400 mg. 
  
The previous paragraph implies that if the amount of codeine per prescription 
exceeds 400 mg except that special prescription, crossed certified by the District, must 
be certified by the insurance fund. The drugs in Table C of Annex 1, to special 
prescription Drugs (crossed) certified by the District, are guarded for three years. The 
prescriptions are numbered and passed in the formulary, the same day. Medicines 
containing the substance methylphenidate are exempted from mandatory Prefecture [22]. 
Under Law 1725/2001 of the Ministry of Health and Welfare the proprietary 
IMALGENE, KETALAR and KETASET (transferred from Table D in C), were added 
to the category C. According to the decision of the Ministry of Health (4/4/2003), 
published in Law 448/2003, pharmaceutical formulations containing competitive opioid 
substances administered by pharmacies with specific "prescription agonists." This 




Law 2955/2001 and serial number, name, specialty, address and telephone number of 
the doctor issuing the prescription. In any given prescription, the doctor should bear 
legible name, address and social security number carrier identification number of the 
patient, etiology, date of issue and shall be signed and sealed by the doctor. Also signed 
by the recipient of drugs after police demonstration identity and finally signed and 
sealed by a pharmacist. The same information will be listed on the stem, while the 
prescriptions and their executives will be kept for three years. All prescriptions are 
simple monorail or stored and numbered month and is indicated ''two-month''. To 
formulary same day mandatory crossed all prescriptions [22]. 
An important issue in the prescribing of prescription is the fact on health 
problems affecting the local competent authority. The certified imported prescriptions 
are filed and available at any time. This section describes the basic rules governing 
those prescriptions: 
 The prescriptions require a visa when the original value is over 60.00 €. Those 
prescriptions are below € 60.00 regardless of how many per month, do not 
require a visa. 
 On repeated prescriptions visa by the auditors doctors will be once and for all 
three (3) prescriptions provided they are numbered in the order of their 
execution i.e. 1, 2, 3. 
 Pharmacists will perform pharmaceutical commands that are certified by the 
examining doctor will dispense only two boxes the first three items, if not 
marked as "treatment month - chronic disease'' or "repeat prescription". 
 All prescriptions are executed within five (5) working days of its disclosure by 
the prescriber. The case that is certified by the auditor doctor than 5 days, so 
runs the day the visa. 
 If a prescription is certified and contains drug off the list without the required 
opinion or more than three or more than two per boxes kind without the words 
"chronic disease - treatment month" will not run. 
 Prescriptions written in category D drugs 
 Prescriptions written medication category EA, such as drugs containing codeine, 




 Prescriptions carrying drugs of Law 1729/1987 except for EA and D categories 
are above require a visa regardless of the amount and value (i.e. crossed 
prescriptions). These drugs are named by the brand names: DELAVIRAL, 
DOVAVIXIN, DUO-EXTOLEN, DUROGESIC, CODEINE PHOSP medicine, 
FENTANYL, FORTAL, JACTUS, NUBAIN, ROMIDON, ULTIVA, 
ZIDERON. 
 
The pharmacist in accordance with the MHW and MSS is by law responsible 
not only for the proper execution of prescriptions and share responsibility with the 
prescriber for participating policyholders. In cases where the disease is referred to as a 
diagnosis in the prescription clearly falls outside the categories for which they 
administered drugs, with reduced or no participation of the insured, then the pharmacist 
will receive a 25 % share or returns the correct prescription for the treating doctor. In 
any other case, the pharmacist is required to collect the share provided by the applicable 
law. For this reason, is presented a synopsis with the disease reduced and zero 
participation share, which must be followed by prescribers and pharmacists to check. 
 
4.2 REIMBURSEMENT OF MEDICAL PRESCRIPTIONS  
 
1. Diseases involving 0 % participation: 
Participation is 0 % for drugs administered in an accident and for prescription in 
maternity (pregnancy- birth- partum). Also patients do not pay the participation to the 
following chronically ill conditions [23]: 
 Neoplasms of all systems and leukemias (anti neoplastic drugs and their 
antidotes, and medicines needed to treat the effects of tumors) 
 Diabetics only insulin 
 People with psychoses for neuroleptics and antidepressants 
 Epileptics on anticonvulsants 
 Thalassaemic patients for chelation drugs and complications of the disease 
 The hemophiliacs for anti-hemophiliacs factors 




 Patients with renal insufficiency undergoing continuous replacement therapy by 
artificial means and having undergone a kidney transplant, patients with 
multiple sclerosis, paraplegics and quadriplegics and patients undergoing 
transplantation of solid organs or fluids for regardless of all the drugs. 
 The insured cytostatic and immunomodulating drugs, regardless of the condition 
from which they suffer. 
 HIV-positive patients on antiretroviral medicines prescribed by the recognized 
reference centers for AIDS diagnosis and recognized hospitals specific 
infections. 
 Children and adults for vaccinations approved each time by the Ministry of 
Health and Welfare National vaccination program. 
 Insured for medicines supplied by pharmacies IKA. 
 
2. Diseases involving 10 % participation : 
 Parkinson's disease and dystonias for antiparkinsonian drugs. 
 Diabetes insipidus to vasopressin and its synthetic counterpart. 
 Chronic rheumatic valvular disease and other valvular, chronic pulmonary heart 
disease, congenital heart disease, coronary artery disease, hyperlipidemia. 
 Connective tissue disease (systemic lupus erythematosus, scleroderma, 
dermatommositis, vasculitis, rheumatoid arthritis, psoriatic arthritis). 
 Osteoporosis and Alzheimer PAGET for drugs affecting bone metabolism. 
 Patients who receive parasympathetics and corticosteroid medications. 
 Fibrocystic disease. 
 Tuberculosis. 
 Chronic obstructive pulmonary disease. 
 Inheritance vase edema 
 Pituitary adenoma. 
 Ulcerative colitis. 
 Disease CROHN. Esp. Cirrhosis of the liver. 




 WILSON Disease’s. 
 Years and acquired immunodeficiency. 
 Vitaminexartomeni rickets. 
 
Also, retirees that are entitled to receive EKAS, by the current law, their family 
members participate with a 10 % share, in the value of medicines.  Figures 1, 2  and 3 in 
Annex B, depict a typical electronic prescription from a private doctor and hospital 
standard prescription. Also figures 4, 5, 6, 7 of Annex B, demonstrate the current e-
prescriptions of EOPYY [22]. 
 
5. ELECTRONIC PRESCRIPTIONS 
 
The prescription of drugs and medical procedures is one of the most critical 
functions in the areas of Health and Social Security after badly affecting both public 
health and public finances. The medical expense insurance funds for 2009 amounted to 
EUR 5 billion, equivalent to 40 % of the annual state subsidy to them. The amount of 
the expense is due to many factors, including inducible, directed, illegal prescription, 
virtual use prescriptions or use them for other purposes. [17] 
The share of all those in charge equivalent to 20 – 25 % of the total sum, and the 
control will lead to savings of around one billion €. About 100 million prescriptions per 
year are respectively performed in Greece. This has led to the inclusion of electronic 
prescribing as an obligation of the country to the text of the Memorandum. [17] 
Along with the funding problems of the current system medley of choices leads 
to significant system failures, suffering policyholders and serious deficiencies in the 
quality of the health services. So-insured citizens are forced to wait in long queues to 
get a prescription. Especially those suffering from chronic diseases should undergo the 
hassle every month. Alternatively, should pay medical visit to get the prescription from 
their private doctor. This translates to multiple medical visits, whether medication 
prescribed by doctors of several specialties. The result is that the difficulty in serving, 
pushes them to deliver their formulary pharmacist who receives them. 




available in the third row, which is a privacy waiver. Some insurance companies require 
from their patients to provide them a prescription for pre-authorization, which in 
combination with commonly reduced working hours the past contributes to discomfort 
and increases their motivation for delivery of prescriptions to a pharmacist. In addition, 
citizens are not protected from mistakes in medication, either prescription or during the 
execution of the prescription. 
Apart from the insured, the current regime creates important problems from the 
health professionals. So doctors in Organizations (mainly those of IKA) facing patients 
practically eliminate any possibility of providing health services with dignity. Also, 
doctors are pressured by their patients to prescribe their drugs of another specialty so 
that they can avoid multiple visits. The pharmacists are forced to market their own 
prescriptions for their patients in order not to lose them as customers, in order that they 
avoid the hassle. Furthermore under pressure from patients to manage their formularies 
blankly themselves to take various free products such as cosmetics, medicines life-style, 
orthopedic shoes, canes, etc. Finally, a very common phenomenon is the monitoring of 
prescribing habits of doctors from certain pharmacies which deliver these data to 
wholesalers and pharmaceutical companies in exchange for credit facilities and 
discounts. 
In terms of social security funds and public entities, they are charged with 
millions of handwritten prescriptions stored in sacks cleared after months and 
controlled sampling. The cost of handling handwritten prescription is estimated at 2.3 
per prescription. As a result, there is a lack of transparency in the production and 
handling of prescriptions and the inability to conceive fraud leads to an enormous waste 
of money. Other consequences are extremely inability to collect important data about 
the habits of health professionals and health of citizens, and hence, the inability policy 
planning, lack of appropriate tools in order for the state to implement policies identified 
(e.g. generics) and the lack of reliable data consumption to stabilize returns from 
pharmaceutical companies. With this bill the institutions founded Electronic 
Registration and prescriptions (IKES), major policy intervention towards modernization 
and transparency of medical services and reducing pharmaceutical expenditure. The 
project is to develop a web application for electronic prescriptions from a medical 
professional, their execution by pharmacists and their clearance from the insurance 




The application will record data for electronic prescriptions from natural and 
legal persons involved in the process flow of the system of electronic prescriptions. It 
will also update with a continuous and ongoing process of data registers of doctors and 
pharmacists / pharmacy through the development of a new operating concept. The new 
system ensures the completeness, quality, confidentiality, integrity and security of data, 
provides opportunity beam and processing data from both internal and external sources 
of information and minimizes the chances of errors in excess of 60 % congestion and 
minimizes the chances of errors in excess of 60 %. Based upon IKA data, current errors 
in prescribing are distributed as follows [18] : 
 Allocation of prescription drugs other 66.0 % 
 Coupon code file except drugs (incl. IFET) 9.9 % 
 Number of different drugs prescribed to 3.8 % 
 Incorrect execution repeat prescription 3.7 % 
 Prescribing more than 2 can without indicating chronic disease 3.3 % 
 Other 10.2 % 
Furthermore it has been estimated that the Electronic Registration and e-
prescriptions will lead to savings of 100 hours per doctor/year, while even more 
important is to ease the workload of pharmacists. It should be noted that the importance 
of the MSS attributes in digital technologies for health, is not only politically 
entrenched, but also well documented by numerous studies and examples of successful 
application abroad. Please note that e-prescribing system already operate in the UK, 
France, Germany, Spain, Belgium, Holland, Luxembourg, Finland, Sweden, Norway 
and Denmark, but also in the U.S. [22]. 
 
5.1 APPLICATION OF E-PRESCRIBING IN GREECE  
As the electronic production, distribution and monitoring of prescriptions and 
referrals for medical procedures is gradually replacing handwritten prescriptions and 
procedures, the provisions of this apply to all Agencies and Health Sector Social 




Security. A prerequisite for the application of the regulations of this is the existence of 
information and communications infrastructure and related applications, which does not 
exist at the same time for all social security institutions. For the sake of effective 
enforcement by all social security Law is introduced, by which the Secretary finds by 
resolution of technical assistance and organizational requirements for electronic 
prescribing and for reasons of legal certainty, clearly states the date applying this to the 
entity concerned. Since this is supervised by another Body Ministry, the decision signed 
by the relevant Minister and the MSS. 
Under Law 3892/2010 (Official Gazette 189/ Α΄), it is established an 
institutional electronic execution and registration of prescriptions and referrals, medical 
examinations. The electronic prescribing is an interdisciplinary critical function, as it 
affects badly Public Health, Social Security and Public Economics. According to the 
explanatory memorandum, the purpose of the Act is to modernize and transparency of 
medical service and reduce pharmaceutical costs. Key prediction is the establishment 
and maintenance of web-based data entry for electronic prescriptions and referrals from 
doctors, implementing their pharmacists and health service units and clearing them 
from the social security institutions [18]. 
The above law takes into consideration of the finding in Communication Law 
356/2004 of the European Commission: "e-Health - Improving health services for 
European citizens: An action plan for a European e-Health Area". Electronic prescribing 
has been included among the examples of integrated health information networks, 
which can link hospitals, laboratories, pharmacies, primary care and social services. 
Also, in accordance with the provisions of the Directive 95/46/EC of the European 
Parliament and the Council of 24.10.1995 on the protection of individuals with regard 
to the processing of personal data and on the free movement of such data, the 
processing of health data allow, among other things, for reasons of public interest, 
provided that they are provided with appropriate safeguards for the protection of 
fundamental rights and privacy of individuals [5]. 
According to the MSS responsible for the implementation of the e-prescribing 
measure is the General Secretariat of Social Insurance (GGKA) and the E-Government 
Social Insurance (IDIKA SA). The measure was piloted by the Agency Security Self-
Employed (OAEE) in October 2010. Before the recent actions - Pharmaceutical Price 




in May 2011. The pharmaceutical expenditure in Greece was double the EU average. It 
seems that in principle there is scope for reducing pharmaceutical expenditure, and 
therefore need to take immediate concerted measures compression. According to a 
recent announcement of GGKA, phases of ET, the requirements of the memorandum 
over the reducement of pharmaceutical expenditure cost are classified into 3 individual 
phases, as follows [8]: 
Phase A 
From 18/10/2010 operates online (web-based) application, which pertains to 
electronic recording and dispensing OAEE is operated by the IDIKA to highlight that 
the project can work efficiently and to measure early results. From the initial findings 
have emerged the following elements: 
 Functions are supported: 
o Electronic prescription from your doctor 
o Electronic prescriptions from the pharmacy 
o Aggregate reports 
 Potential users: 
o 4,100 affiliated doctors OAEE 
o 9,500 pharmacies 
 Usage information: 
o 10,000 prescriptions daily 
Phase B 
         On 24/1/2011 launched the first phase of expansion to larger funds (OAEE IKA 
fans, OGA), covering 90 % of the insured. The integration of these doctors funds done 
gradually. 
 Average daily prescriptions posted: 22,000 
 Average daily prescriptions that run: 17,000 
The first users reacted somewhat cautiously, mainly because of the slow 
response time of the system, lack of coding, inability to access the help desk, running 
and some other technical reasons. At this stage the system is enhanced by additional 




give users sufficient structure telephone support. The potential for expansion came from 
sponsorship of the National Bank of Greece, amounting to 1,500,000 €. 
Phase C 
In phase C is already designed an integrated extension of the project to cover all 
operational needs of the System. Among others will be implemented: 
 Rules prescribing, indications and contraindications of drugs 
 Preventive Controls 
 Interoperability with social security, Dias, hospitals 
 Digital signature 
 Business intelligence 
 Operational Support Contract (SLA) 
 Direct technical user support (help desk), etc. 
For the expansion project has been designed by an invitation to tender, the 
timing of which provides as follows: 
From the above flow phases of evolution IO stated that the project is treated as 
an individual project Informatics. The date of application IO thrived in a very short 
period of time, "pilot use" and to meet the mandatory requirements, this Memorandum, 
to reduce pharmaceutical expenditure. The challenge, as emerged from the consultation 
is the smooth development of an integrated technology platform that can manage 
effectively, seamlessly and over time, both as prescription and referral examinations of 
all members [9]. 
The IO should provide and any additional functions, for reasons of urgency not 
achieved in the pilot, including a full-encoding, interoperability, business intelligence, 
etc. The electronic prescribing, as a new procedure in the field of health and social 
security, aimed at large and uneven set of participants (citizens, doctors, pharmacists, 
insurance funds, etc.) affecting their behavior and relationship. Focal point for the 
proper functioning of the measure is whether the structures and processes introduced by 
the implementation of e-prescribing, shape behavior toward desirable goals, set by the 
policy. Features of the attitudes of patients, the literature mentions the term "asymmetric 
information", while the characteristics of the attitude of doctors term "induced demand" 




investigate the contribution of modern tools of management to change these behaviors 
or at least to a degree control. 
The existing institutional framework, which provides that the doctor and the 
pharmacist, will abide by confidentiality rules are further questions to adequately 
inform the insured of the potential manipulation of data generated by contact with their 
health care providers as to the confidentiality that must be met, and rights can be 
exercised. The reliability of the system requires smart solutions to the issue of sensitive 
information and protecting them to serve in a manner consistent with the guidelines of 
the European and Greek politics. In light of the above findings, was structured the 
themes and defined individual objectives, which were: 
 Provide the full roadmap implementation of such a project, 
 Consider alternative sources of funding, 
 Identify extraneous but relevant factors and 
 To include stakeholders, users and citizens, integrated picture. 
 
5.2 DATABASE OF E-PRESCRIPTIONS 
Article 5 of Law 2472/1997 [10], regulates the establishment and maintenance of 
a database application electronically record and prescriptions, which according to 
Paragraph 1 shall be supervised by the General Secretariat for Social Security and 
especially the Service Control Health Costs of Social Security (YPEDYFKA) due the 
specific control and supervisory powers conferred on it by the legislature [11] and the 
Department of Software Applications. 
IDIKA SA already maintained the purpose assigned to it by the legislature or 
under statute (Article 3) Database insured all of Social Security under a single Social 
Security Number (SSN Register) explicitly provides searchable items insured using 
SSN for the purpose of identification of members by registering and execution of the 
prescription. In Paragraph 3 it is defined explicitly and restrictively the purpose of the 
base-line registration and application execution prescriptions involve support of Social 
Security to clear prescription and cover the drug treatment (Article 5 § 3 a), to support 
the more specific control prescriptions and overall supervision for all health services 
provided to insured persons and pensioners of Social Security and enabling the 




care, in order to produce the relevant policies in the relevant fields. The fulfillment of 
these objectives requires access to the relevant bodies, such as the General Secretary for 
Social Security and Service Control Health Costs of Social Security, while Article 4 
introduces the access and the data on which it is permitted under the condition of 
respect the principle of proportionality. Technical and organizational security measures 
in infrastructure, such as information systems and data are kept, in order to protect the 
rights of patients regarding their health data [11]. 
 
5.3 BENEFITS OF E-PRESCRIBING 
The electronic prescribing bring significant strategic benefits for healthcare as a 
whole - if designed and implemented in an integrated manner over time. It should 
therefore be accessed this way, and rather not as a truncated work. The expected 
economic benefits can be substantial. Directly but not guaranteed. Required time about 
5 years to start producing the investments, as reported by the rapporteurs Jensen and 
Larson. The exact value of strategic gains depends on the performance of the healthcare 
system before the introduction of new services and the degree of interoperability with 
existing infrastructure. But directly attribute these services by combating illegal 
transactions (fraud), as pointed out by Stroetmann. It must, therefore, be treated as 
"project funding" from the beginning in an integrated way (Address financing 
challenges), which ensures the necessary resources over time according to the Swedish 
model [12]. 
 
5.4 DISADVANTAGES OF E-PRESCRIBING 
The disadvantages of e-prescribing are summarized as below: 
To apply, there must be electronic computers, both in private clinics or hospitals and 
pharmacies. Most pharmacies already have PC’s, but only 20 % doctors has already a 
computer. An important factor is the ignorance of professionals of larger age, who do 
not have any computer skills. The computerization of insurance organizations is 
essential. The use of electronic requires the knowledge of computers. An important 
notification is the safety of data, moving through the system and the database which 
will store all the data .Another big disadvantage is the cost of purchasing hardware 




5.5 LONG-TERM STRATEGIC PLANNING IN E-PRESCRIBING 
Despite the fact that e-prescribing, initially may be considered as a "simple" 
project, international experience shows that developing electronic prescribing 
nationwide is a very complex and long-term project. It is characteristic that the printed 
or paper based prescription remains part of the process for several of years, along with 
the electronic submission (e.g. in Sweden after 10 years of implementation, 15 % of 
submissions is still in print). Based on the overall European experience (relevant 
recommendation of Stroetmann), the development of a national strategy for e-
prescribing - part of an overall strategy for e Health - is usually the first step in a long 
term effort to achieve a high level cooperation at the national level on these issues. The 
second phase includes the steps to obtain the consent and acceptance of this strategy by 
all stakeholders in the public and other stakeholders (doctors, pharmacists, industry) [17]. 
Part of this design is the provision for a mechanism for [18]: 
 Evaluation of the impact and evaluation of the efficiency of establishing regular 
evaluation and impact assessment 
 Establishing effective governance structures of the project (establish e-Health 
governance framework) and management of change process. 
 
The successful implementation of an e-prescribing project involves shaping the 
national framework for the standardization of health data. This need is directly related 
to providing high quality services to the citizens, to be achieved through the collection, 
longitudinal compliance, processing, evaluation and feedback of Health System with 
high quality data from the operational systems operators. All developed countries in the 
EU, in one form or another, have developed mechanisms for producing national 
standard minimum data sets and encoding, which are accessible and available to all. 
Thus supported the competitive growth of the National Medical Industry of Informatics. 
At European level, critical success factors of the system are non-technical measures 
(relative contributions of Jensen and Stroetmann), including [12]: 
 Provide support to public and patient (improve support for citizens and patients). 
Particularly critical success factor is the degree of acceptance of new services by 
the society and patients. Developing appropriate communication, education 




 The interface of the service with existing infrastructure (re-use individual patient 
and other health system data). The degree of acceptance of new services 
depends largely on ensuring interoperability with existing IT infrastructure. 
 Participation and mobilization of stakeholders. This one involves clinicians, 
industry and other stakeholders. From the above it is essential that the beginning 
dialogue and the effective mobilization of all stakeholders. The ways to achieve 
this goal depends on the specificities of the national environment. 
 
6. LEGAL OBLIGATIONS IN E-PRESCRIBING 
6.1 LEGAL OBLIGATIONS OF DOCTORS 
Article 3 of Law 3459/2006 [14] defines the obligations of doctors, who are either 
doctors of Social Security or affiliated with them, for electronic filing of prescriptions. 
These obligations relate both to record in implementing e-prescribing and other process, 
the rights and obligations regarding electronic recording itself. Specifically, Article 2 
defines specific data must be declared by doctors, in order to record in the application 
and their identification and to ensure the validity and confidentiality and additionally 
control for the registration of prescriptions. For clarity explicitly states that the 
registration and identification of necessary conditions for the electronic filing of 
prescriptions [14]. 
 Paragraphs 3, 4 and 5 specify the registration process, the necessary minimum 
content that must be registered with the doctor, such as the diagnosis, name, brand name 
or active ingredient, dosage, strength, quantity of prescription drugs, prescription 
category and the percentage participation of the insured. The prescription as listed in the 
application allows the unique identification and integration of the electronic 
registration. Special arrangements are made by granting proprietary or preparations 
containing substances listed in Article 1 of Law 3459/2006 [14].  
Doctors are given the option to choose either the diagnosis from the list of coded 
diagnoses, when importing the code or enter a free text description of the diagnosis. 
Furthermore, onto Paragraphs 7 and 8 are displayed the rights of doctors dealing 
specifically with the possibility of stopping the same electronic process prescriptions, 




themselves in the past. These actions are able to assist in providing medical care to the 
patient and update their records and to have oversight of prescriptions.  
Article 9 also specifies the obligations regarding the availability of infrastructure 
(equipment, internet connection) necessary for the registration, identification and their 
connection with the implementation of electronic registration and dispensing and 
processing, recording and printing of electronic prescriptions [14]. 
 
6.2 LEGAL OBLIGATIONS OF PHARMACISTS 
Law 3459/2006 [14] affiliates with the respective social security institutions for 
electronic recording of the execution of prescriptions. The pharmacists are bound by the 
provisions of this or are affiliated either individually contracted through contracts 
awarded by pharmaceutical associations to which they belong. Specifically with Article 
2, are defined the elements, required to state pharmacists to allow for the inclusion in 
the application and their identification and to ensure the validity and confidentiality and 
additionally control for the execution of prescriptions. As in the case of doctors for 
clarity explicitly states that the registration and identification of necessary conditions 
for the electronic filing of prescriptions. 
 Further, in Paragraphs 3 and 4 is described the e-registration process execution 
and data entered in the application and it is necessary to determine both the drugs / 
medications administered and the chemist who performed the prescription. Article 5 
ensures the completeness and unity of computer records introduced the requirement for 
pharmacists to register themselves in the application content handwritten prescription 
on the strict condition that the handwritten prescription issued following emergency 
illness and doctor is not affiliated with the social security institution of a patient who 
presents a handwritten prescription. 
Due to electronically record the prescription and auditability of the Social 
Insurance Institution deleted for electronic prescriptions visa for prescriptions, cost 
more than 150 € and in the case of administration or proprietary preparations containing 
substances Tables A'- D 'of Article 1 of Law 3459/2006 [14]. Paragraph 7 refers to the 
integration of performance: For the best and most complete control until the full 
electronic management system prescribing, pharmacists still have the requirement to 
affix the authenticity of pharmaceuticals executed on printed copies of completed 




Paragraph 8 concerns the special case of the gradual execution of a prescription. In 
Paragraph 9, the pharmacists are entitled to review electronically of the prescriptions 
themselves perform, while in Paragraph 10 sets out the obligations of pharmacists as to 
the availability of infrastructure necessary for registration, identification and their 
connection with the implementation of electronic registration and execution of 
prescriptions and the registration of the execution and printing of electronic 
prescriptions. 
 
7. PRESCRIBING PROCEDURE 
7.1 RULES OF PRESCRIPTION 
It is noticed that under the current Law, the Comprehensive Health Care 
Regulation and EOPYY reports issued by the Agency, the following rules prescribing 
must be followed by doctors, as members of the Organization. Prescription for insured 
in EOPYY can be done by [12]: 
 Medical EOPYY permanent and contract working in polyclinics and 
dispensaries EOGIYY. 
 Family doctors and doctors who contract with the EOPYY. (With ordinances set 
for panel on the vehicle ceiling doctor’s visits and pay per visit and only 
electronic prescriptions except where there is weakness in the system where the 
above procedure will be done manually in a single formulary former IKA - 
ETAM) 
 Medical specialists in outpatient government, military and university hospitals 
have been certified in electronic prescribing. 
 Medical specialists and service debtors of rural health centers and regional 
clinics certified in electronic prescribing. . 
 Qualified junior doctors and medical treatment in GHS hospitals and other 
public hospitals and health centers. 
 Doctor outpatient private non-profit hospitals that are certified in electronic 
prescribing. 
 Doctors clinic of the Greek Parliament, 




 Doctors surgeries Security Forces (Greek Police and Fire), only with the 
Electronic Prescribing after certification. Please note that e-prescribing will be 
directly applicable to the Units and Health EOPYY, once completed the 
purchase of equipment and the electronic interconnection of Units. 
In addition they can prescribe [12]: 
 "Not affiliated with EOPYY private doctors certified in electronic prescribing 
(at private expense) for an electronic prescription only," private doctors certified 
in electronic prescribing, affiliated KAPI and aged care units and only for 
issuing electronic prescriptions (visits not be charged to the Agency). 
 The private doctors can prescribe to 2 prescriptions a month for each insured 
and covered treatment needs month or quarter for chronic diseases. 
 From the above excluded individuals 
 Allergists doctors who administered prescription formats, since desensitization 
vaccines are not registered in e-prescribing system. 
 
7.2 GENERAL PRESCRIBING 
Doctors who provide services to its insured in EOPYY under Paragraph A of 
this. Require [23]: 
 To comply with the Law, conditions of contract, medical ethics, the 
Comprehensive Benefit Regulations and circulars issued by the competent 
Ministries and EOPYY issued each time on the way, time and terms of delivery 
medicare. 
 To control and health booklet to determine whether the person presents for 
examination identical to that indicated or shown in the passbook health while 
assuring that no insurance capacity. 
 To record the medication in a health booklet to members of the IKA and OGA 
and copies of orders for insured health care supporters, and OAEE-TYDKI. 
Check the entries for any previous medication for the same disease. 
 Examine the insured before issuing the prescription. 
Doctors are required to register as users on the system for electronic 




Article 3 of Law 3892/2010 [17]. If it is impossible to access the e-prescribing system, it 
is possible to issue handwritten prescription in uniform formulary which records all the 
data required by the Law 2089/1998 [17]. Electronic recording of all prescription drugs 
from pharmacies to insurers has become mandatory [12], regardless of how prescribing 
prescription from the doctor (electronic or handwritten), provided that each handwritten 
prescription entered electronically by the pharmacies. Doctors who prescribe 
manuscripts are burdened with the payment of compensation to pharmacies that register 
the prescriptions. Handwritten prescriptions in no way compensated and pharmacies 
may not require payment for prescriptions. With decision of the MHW and MSS was 
the amount, the recovery method and any other details on the implementation of this 
provision, while the No. 10480/14-03-2012 document EOPYY implementation of the 
new measure suspended until further notice [18]. 
To prescribe proprietary pharmaceutical action relative with the disease, and 
only for the approved indications and the approved dosage as described in the Summary 
of Product Characteristics (8PG) and only for diseases of expertise, according to the 
provisions of PD / Tosh 121/08 and Article 8 of Law 3457/2006. According to Law 
4052/2012, from 1 April 2012 all doctors will prescribe their policyholders 
Organizations making use exclusively the chemical name (active ingredient) of drugs of 
10 largest consumption in active substances for which no medicines patented and 
generic, excluding those for chronic diseases. With No. DYG3 (a) / GY/149 the MHW 
and MSS identified the specific therapeutic categories. From 1 June 2012 the 
prescription by active substance became compulsory and universal. The National 
Medicines Agency shall list the chemical names of the active ingredients and their 
respective trade names of all the medicines, which display on the site until March 31, 
2012 [12]. 
Doctors must not repeat the prescription drug if the dosage indicated in the 
prescription required and the timing is not justified by the exhaustion of the allocated to 
the previous prescription. Doctors are required to disclose only one unit where 
proprietary acute cases where they consider that the diagnosis is not completely secure 
and consider that for this reason there is no certainty about the effectiveness of 
treatment. More than one unit and up to two proprietary prescribed only where 
absolutely necessary to continue, this treatment the patient's time, for which there is not 




according to the dose of doctor. The above does not apply to packages containing a dose 
packaging for pharmaceutical specialties work necessities [12]. 
In cases where the insured is following a stable medication, determined by a 
medical specialist, medication or a specific time period of two or three months and to 
serve the insured, the doctors of EOPYY, permanent and contracted, should issue two 
months and prescriptions of three months [12], respectively in a sheet. Three-month 
prescriptions will be issued electronically only when done by amendment IDIKA. The 
prescriptions-month period may be issued and manuscripts, as applicable to the 
manuscript, which will be noted in the corresponding field on the prescription and the 
handwritten will require endorsement by the examining doctor. There also remains the 
possibility of a "repeated formula" three months insured patients suffering from chronic 
diseases and constant follow treatment in three (3) continuous sheets. 
The rural doctors have to prescribe only one unit formulation. Exceptionally and 
only if a single dose injectable each, the rural doctor may indicate more than one unit of 
a drug, as much as is necessary to cover treatment. Also may be prescribed for 
chronically ill insured prescription treatment for up to one (1) month and "repeat 
prescription" three months only on advice of doctor specialty. The opinion is as long as 
doctor has told specificity but cannot exceed two years from its adoption. Residents 
prescribing in emergency situations for the patient one box per drug or chronically ill, 
with expert advice, quoting name, SSN and specialty of the treating medical specialist 
and date advice. Not in any way encourage insured persons to perform the prescriptions 
issued to a particular pharmacy and do not produce their own prescriptions to the 
pharmacy for execution. The breach involves and disciplinary action against the doctors 
by the competent disciplinary bodies. Prescription from pharmacies of the organization 
referred to on G55/863/30-9-2011, and G55/891/29-12-2011 1155/3-2-2012 EOPYY 
documents.  The availability of these drugs will be available with a prescription which 
will be accompanied by an opinion State Hospital or private clinic for medicines Article 
12 Paragraph 2 of Law 3816/2010 [17] and other drugs by treating opinion as required by 
the disposal operation. Doctors, who prescribe drugs that are bound and delivered by 
pharmacies of EOPYY, must: 




 Instruct the insured to what pharmacy EOPYY be approached for the execution 
of the prescription you need to consider the case of a special committee with the 
documents they need, not to suffer the insured. 
 Must not list the specialties they prescription with the same prescription from 
private pharmacies. 
 Indicate the prescription the words "Sponsored by the pharmacy EOPYY " 
 Prescription to attach to the opinion of the respective medical specialty, from a 
public hospital or private clinic, or if the same doctor at the same time. 
 Be granted to the insured any additional documents for the administration as 
contained in the documents and G55/863/30-9-2011 1155/3- 2-12. 
 
When doctors prescribe expensive medications and special treatments that 
require approval by a committee of EOPYY (Article 9 of the Unified Rules EOPYY 
providers) are required to issue an opinion on, check the documentation necessary to 
guide and inform the insured. Particularly for prescription drugs not marketed in Greece 
(external), the doctor must complete a special form A and gives the patient 
examinations from where the disease was identified and referred to in the course of the 
disease and refer the patient to NMY of local EOPYY to documents sent to the 
Commission [12]. 
 
7.3 HOSPITAL CONSULTATION PRESCRIPTIONS 
The prescriptions must be accompanied by medical reports (hospitals or private 
clinics) in the following cases [39]: 
1. Preparations whose authorization has limitation of disposal 
It is described in the "for hospital use only" (Gazette No. 335/9-5-89 A6/1398 
1st & 2: "The pharmaceutical products which were authorized under ". The term "for 
hospital use" may be administered outside of hospital pharmacies, in private clinics and 
in patients who continue a hospital treatment at their home, provided that the 
prescription of a private doctor or the Insurance fund must be accompanied by a 
certificate duplicate the clinic or hospital. Basically, this is an extension of hospital 




2. Preparations for GG 569/30-4-2010 
3. Preparations in dispensing them include processes which take place in a hospital or 
clinic, as described in their supply 
The issue of medical reports (hospital or private clinic) must be done by a doctor 
who made the diagnosis in a hospital or private clinic, during a specific time period, 
which may not exceed the two (2) years. In case not, the doctor does not mention the 
treatment period. Medical examinations (hospitals or private clinics) in order to 
accompany the prescriptions, may be original or certified copies. Additional copies of 
medical reports for agents, whose authorization has limiting distribution, will be kept in 
the pharmacy for two (2) years (GG 335/9-5-89 No. A6/1398 Fri the 4th:  for 
formulations whose authorization has limiting distribution "for hospital use only" the 
original advice from the clinic or hospital shall be submitted by the pharmacy to the 
fund, in order to cover the cost of the therapy. Afterward, the copy will be kept for two 
(2) years [35]. 
The medical reports issued by formations of the GHS, in order to be valid, it 
will be necessary, among other things, to bring [35]: 
 Seal of the Hospital 
 Seal with elements of doctor specialty 
If the medical report is issued by a private clinic, it would necessarily bear the 
logo of the clinic, the appropriate seal and stamp with the elements of doctor specialty 
[35]. 
 
7.4 OBLIGATIONS OF DOCTORS IN E-PRESCRIBING 
 Doctors are required to register as a user of NHI managed by the Agency of 
"Electronic Governance Social Security - IDIKA S.A.", on behalf of the General 
Secretariat for Social Security. Also, they have the obligations laid down in particular in 
the following Paragraphs [34]. 
When registering a prescription, the doctors mark the following [34]: 
 a) Last Name, First Name, Middle Name, Mother's name b) professional license 




 Register and date of enrollment 
 Medical societies to which they belong 
 Tax Identification Number 
 Identity card number or passport number for foreign doctors 
 Details of work address 
 Password health unit 
 Data contract with the Social Security Administration 
Doctors who are registered as users, are identified when they enter their 
identifiers, username and password. The registration and identification is required for a 
electronic filing for prescriptions and referrals, defined by the law. Doctors, after 
undertaking the identification of the patient by showing their health booklet and use of 
serial number, they register online the appropriate prescription and specifically register 
the patient’s diagnosis, medications and / or referrals. Regarding the drugs, they enter 
the name (brand name or active ingredient), dosage, quantity of prescription drugs, 
prescription category and the percentage of the insured patient. Doctor’s diagnosis is 
selected from the list of coded diagnoses or either enter free a text description of the 
diagnosis and afterward import the prescription drugs from the list, approved by the 
Greek Organization for Medicines (EOF), legally circulating pharmaceuticals, under the 
general and special provisions of disposal of pharmaceuticals. If the prescription is 
granting proprietary or preparations containing substances contained in Tables A' – D of 
Article 1 of Law 3459/2006 (Government Gazette 103 A) and Paragraph 8 of Article 1 
of Presidential Decree 148/2007 (Government Gazette 191 A), the prescription includes 
special marking, as provided in Paragraph 7 of Article 1 of p.d.148/2007 [35]. 
Referrals to doctors record the type of operation or Investigations that should be 
executed. Regarding the medical procedures, doctors may introduce a free text reason 
for referral to the insured in the respective field (when necessary). Also, they have the 
opportunity to choose the diagnosis, using the international coding standards. The 
prescription contains elements of the doctor who registered the prescription, the 
registration date and the start and end dates of the execution. Any prescription or 




the form of barcode. In case of a repetitive prescription, these are also recorded 
automatically, but the registration date and the respective start and the end date of the 
medical execution must be noted [36]. 
After confirmation of comprehensive and successful e-registration of a 
prescription and referral, doctors print the copy of the prescription or registered referral. 
Afterward the prescription is signed and delivered to the patient, who hands it to the 
pharmacist or healthcare service unit, in order to perform the prescription or referral. If 
the prescription is granting preparations, containing substances from Tables A – D of 
Article 1 of Law 3459/2006, doctors printout of the prescription and these are kept for 
three years, as well as the handwritten prescription, which accompanies the electronic 
prescription. Prescriptions are made within five (5) working days of its registration [34]. 
Doctors can cancel prescriptions or referrals that have been registered, in case 
that they are not enforced. Doctors have the ability to review, prescriptions or referrals 
that have been registered by them, online. If it is necessary to determine the appropriate 
medication, doctors can consent the patient to access the data of any previous 
medication or medical transactions, recorded by other doctors. Doctors are allowed to 
use these data exclusively for the aforementioned purpose. Access is recorded in 
electronic prescribing. Doctors are required to have the necessary infrastructure for the 
registration, identification and their bandwidth connection, while processing, recording 
and printing of electronic prescriptions and referrals [34]. 
 
7.5 OBLIGATIONS OF PHARMACISTS IN E-PRESCRIBING 
Pharmacists contribute, either individually or collectively, with their social 
security required to register as users and managing body "e-Government Social Security 
- IDIKA SA", on behalf of the General Secretariat for Social Security. They have the 
obligations laid down, as described in the following Paragraphs [34]. 
Upon registration pharmacists confirm the following [34]: 
 Last Name, First Name, Middle Name, Mother's Name 
 Name of the business of the pharmacy, as the legitimate representatives 
 Number of professional license 




 Pharmaceutical Association to which they belong and their corresponding 
identification number 
 Tax Identification Number 
 Identity card number or passport number, for foreign pharmacists 
 Date of profession / trader 
 Code and address information of the pharmacy 
 Data contract with the Social Security Administration 
Pharmacists who are registered, are identified when they enter into the system 
using their identifiers. The registration and identification is required for the online 
registration and prescriptions, as defined in this law. Pharmacists enter the application 
password prescription electronically and the collection of the data of the patient, shown 
in the prescription registered with the information provided, by the patient's health card 
[34]. 
After undertaking the identification of patient that has registered the electronic 
prescription, the pharmacists import the drugs for sale in the application by inserting the 
two (2) bar codes that exist in the film authenticity of any medicinal product. After 
paying the stated participation and delivery of drugs by pharmacists, the prescription is 
considered as "executed". The entry includes the date of execution, details of 
proprietary delivered to the patient, accompanied by their barcodes and the cost (total 
and participation) [37]. 
Exceptionally, in cases of emergency disease if the patient presents handwritten 
prescription, which has been adopted by doctor, patient or an account with him but 
covered by insurance companies. During the general provisions, the pharmacist is 
obliged to electronic filing of the information contained in his handwritten prescription, 
including the patient and the doctor. After the complete and successful implementation 
of e-registration of prescription, pharmacists print the copy of the executed prescription, 
which is mounted by authenticity tapes. The copy is signed by the insured or the person 
who receives the drug and pharmacists sign and stamp the copies, according to current 
Law. If the prescription grants proprietary or preparations containing substances that are 
contained in Tables A – D of Article 1 of Law 3459/2006, pharmacists printout the 




registration in accordance with the current Law. If it is desired by the insured, 
pharmacists grant to the patient a printout of the executed prescription [34]. 
Pharmacists may perform some or gradually one prescription at a time, by 
entering the information specified in Paragraph 4. The formulations are given to each 
partial execution. The pharmacists have the potential review of prescriptions executed 
electronically, by them. Pharmacists are required to register every prescription 
regardless of whether the patient is covered by an insurance company. Pharmacists are 
required to have or acquire the necessary infrastructure for recording, identifying and 
connecting with the central system, for the processing, recording and printing of 
electronic prescriptions [38]. 
 
7.6 SANCTIONS 
The breaches of the rules on prescribing, impose disciplinary, administrative and 
criminal penalties in accordance with the provisions of Law 121/2008, as modified by 
the provisions of Law 3846/2010, Law 3996/2011 and Law 4047/2012. For permanent, 
contract fixed or indefinite doctors and dentists of EOPYY and non-panel practitioners 
and dentists who violate regulations EOPYY, whether it be referred to the appropriate 
disciplinary body for violations of: 
 Over prescription: greater quantity than that required to treat the disease, 
according to the regimen that necessarily indicated on the prescription and as 
defined by the SPC of the drug for this indication and on therapeutic protocols. 
 Induced demand: 
o Prescribing that does not match the health needs of the patient 
o Medicines therapeutic effect has not been established 
o Administering experimental treatment 
o Prescriptions the patient’s demand 
 Directed prescription: 
o Prescription pharmaceuticals specific producer 
o Indication of the prescription execution to a specific pharmacy 
o Denial of service members 




 Violation of the provisions of PD 121/2008 [23] as amended, is imposed by 
decision of the President, for up to two (2) years. 
The decision of the President of EOPYY expires with the passage of one year or 
by issuing a disciplinary decision by the competent disciplinary body. The above 
decision of the President of EOPYY issued, after calling the doctor to provide written 
explanations, explanations which will be deposited within five (5) days of notification 
of the call. This provision extends the backlog. In case of breach of Article 2 of Decree 
121/2008 [23], imposed the following sanctions: 
A. Liability for damage caused by prescribing increased by fifty percent (50 %). 
B. Fines ranging from 3.000 € to 15.000 € depending on the frequency and severity 
of the offense. In cases cropped executed prescription considered by the 
examining doctor for violation of rules prescribing the Agency receives the 
value of the prescribing doctor. The certified non-contracted prescription before 
receiving the full operation of EOPYY and then not contracted must return the 
prescriptions they have received. 
 
7.7 MEDICAL ERRORS 
The evaluation of private diagnostic laboratories and private clinics is aiming at 
the certification, according to the age of technological equipment, health professionals, 
the infrastructure and afterward reporting all the medical errors to the Deputy Health 
Minister. This intention of the Ministry is to place the formal change to a different path, 
compared to the past, in the field of medical errors [33]. 
History should be remembered, because until the recent past few references that 
were made to medical errors, only a few cases reached the courts. The year 2000 the 
medical liability cases who took the path of justice was only 25. The current change in 
the official attitude of the state is a natural progression. The legislative framework had 
already launched its new course. Initially, in 1992, the Law on the protection of hospital 
patients and more decisively in 2005, the new Code of Medical Ethics, ended the 
paternalistic view of medicine in Greece. Additionally, complaints about medical errors 
are now multiplying and constantly increasing [33]. 
 It’s about time for the official state than someone has the obligation to bring out 




every mistake is due to a "malfunction" of health services. The prevailing logic of the 
"cover-up" has simply preserved these glitches and caused further errors. The first 
priority is to create a formal mechanism for collecting complaints about medical errors. 
This mechanism should gather all the legal claims (lawsuits and pipelines) and 
complaints which ones, would not proceed in court. It is not possible even for the 
present era, the lack of official statistics of medical errors in Greece [33]. 
Certainly, such a data collection will have no value, unless without a subsequent 
evaluation.  Evaluation which should be done by experts in this level will have the 
sense of thorough study of the data and then identifying the system’s malfunctions, or 
ways of intervention and improvement.  The political leadership of the Ministry of 
Health has officially brought out the issue of medical errors, in order to create a new 
perspective in the evaluation of health units. It is important from here on, that this 
prospect should not be limited to recording errors, but take decisive and further 
interventions. It's the only way to succeed in these tough economic times can offer to 
the Greek patients, safer health services [33]. 
7.8 CROSS-BORDER PRESCRIPTIONS 
In the light of the recent adoption of the Directive on Patients’ Rights in Cross-
Border Healthcare, the Pharmaceutical Group of the European Union (PGEU) has 
called for a comprehensive approach to cross-border prescriptions. Under the terms of 
the Directive, the European Commission will develop key features of the cross-border 
prescription system, including a non-exhaustive list of elements to be included in 
prescriptions. In a study of European prescription practices undertaken in 2009, PGEU 
found that prescriptions varied significantly across the EU, including different required 
information, validity periods, numbers of permitted items prescribed and the kind of 
forms that can be used to write prescriptions. [41] 
In a statement adopted on the 21st March, PGEU points to various difficulties 
inherent in a cross-border prescription system, including medicines with different brand 
names, and the difficulties in identifying prescribers from other countries. The 
statement calls for the list of essential elements to be developed by the Commission to 
take into account the full range of EU practices with regard to prescriptions, including: 
Prescription by International Non-proprietary Names (INN), Medicine Indication, 
Authentication and Validity of Prescription and Identification of Dispenser. [41] 






The Greek Health System stood at the beginning of the foundation of the 
Official Greek State. Its obligation is to provide medical care for all Greek citizens. 
According to international criteria, the Greek health system ensures greater number and 
range of services to its members. However this situation for many years was associated 
with unethical practices, like phenomena of over-prescribing. 
However, despite all these drastic changes, the basic structures, rules, 
regulations and principles, relating to prescription, remain unchanged. The former 
setting is often combated with over-prescription and the establishment of economic 
interests in the area of health. The existing legal framework adequately, defines the 
rules for handling and marketing of pharmaceuticals, and is constantly updated with 
decrees and ordinances. 
In this diploma thesis it has been described the existing model of medical 
prescriptions in Greece and have been given adequate information about their basic 
divisions, their kinds, their formal look, and their compensation. Also it is described the 
course of the prescription, from the doctor to the pharmacist, harmonized with modern 
electronic prescribing. 
The overview of the most important mentioned information about medical 
prescriptions is clearly summarized at Table 1. 
Furthermore they have been collected samples of medical prescriptions and has 
been explained their way of handling by the doctors and the pharmacists. As last target 
of the diploma thesis, it was shortly analyzed the current situation of the greek health 
and social system and their parameters.  
The provision of health services is performed by medical actions and medical 
prescription is a major part of this. In the past few years (since 2009), electronic 
prescriptions are adopted and aim to squander public finance and streamline the 
financial, earmarked for the health sector. Nowadays the usage percentage of electronic 
prescriptions in whole Greece is reaching 90 % with perspective to achieve in few years 









Main Explanation  Special Information 
Types of 
prescriptions 
 Electronic Prescription 
 Private doctor prescription: in a 
not standard, hand – written form 
 Veterinary Prescription: in a not 
standard, hand – written form 
 Green-type forms: It is a standard 
form, filled by hand 
 Medical devices prescriptions 
 Habituate red line prescriptions 
 They can be either from 
private doctor or from 
hospital  
 The green-type forms are 
used by doctors or hospitals 
when the electronic 
prescription system is not 




 The repeated prescriptions can be 
either for 2 months or 3 months 
 The 2 months prescription 
is at a single prescription 
and the patient gets once all 
the medicine together. The 
3 months prescription are 3 
different prescriptions and 
the patient takes his 









 Electronic Prescription: 7 
working days 
 Hand - written prescription from 
private doctor: unlimited 
 Veterinary Prescription in a hand 
– written form: Not specified 




 Can be prescribed in any type of 
prescription, they must be with a 
special single or double red line 
hand written form 
 The habituate special red 
line forms must be kept in 













 In the compensated prescriptions 
only 3 different medicine are 











 Acc. doctor’s decision, in 
all types of prescriptions 
 Pharmacist can choose 
alone the concrete brand of 




 Only in the electronic prescription 
can be substituted the brand of 
medicine  
 Pharmacist can choose 
alone the concrete brand of 
medicine, only with 
patient’s agreement 
Extra fee per 
prescription 
 1 € per prescription 
 This fee is collected by the 
pharmacy and is given to 
the state as a tax 
Storage of 
prescriptions 
 in the pharmacy 
 Electronic prescriptions: 1 month 
 Hand-written prescription from 
private doctor: No obligation to 
keep or save 
 Veterinary prescription: No 
obligation to keep or save 
 Every month the pharmacist 
must submit the electronic 
prescriptions and the green 
type prescriptions to the 
insurance companies in 




 Only electronic prescriptions and 
the green-type form prescriptions 
are compensated 
 The amount that is paid by 
the patient can be: 0 %, 10 
%, 25 % according to the 
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10.1 DRUGS CLASSIFICATION IN GREECE [36] 
TABLE Α' 
1. DESOMORPHINE-.DIHYDRODESOXYMORPHINE 
2. DET: Ν, N-DIETHYLTRYPTAMINE 
3. DMHP: (DIMETHYL-1, 2 HEPTYL) -3 TETRAHYDRO-7, 8, 9, 10 TRIMETHYL-6,6,9, DIBENZO -6Η 
(Β, D)PYRANOL-1 
4.   DMT: Ν,Ν - DIMETHYLTRYPTAMINE 
5. HEROINE: DIACETYLMORPHINE 
6. CANNABIS ΕΤ RESINE DE CANNABIS 
7. CETOBEMIDONE. (M-HYDROXYPHENYL) -4 METHYL 
1 PROPIONYL - 4 PIPERIDINE 
8. (+)- LYSERGIDE, LSD, LSD-25: (+)-N, N-DIETHYL-LYSERGAMIDE 
9. MESCALINE: TRIMETHOXY-3,4,5PHENYLETHYLAMINE 
10. PARAHEXYLE: HEXYL-3 TETRAHYDRO-7, 8, 9, 10 TRIMETHYL-6, 6, 9 DIBENZO-
6H (Β, D) PYRANOL-1 
11. PCE: N-ETHYL -1- PHENYLCYCLOHEXYLAMINE 
12. ΡΗΡ OR PCPY: 1 - (1-PHENYLCYCLOHEXYL) PYRROLIDINE 
13. STP, DOM: DIMETHOXY-2,5 METHYL-4 PHENETHYLAMINE 
14. TCP: 1-[1- (2-THIENYL) CYCLOHEXYL]PIPERIDINE 
15. PSILOCYBINE: O-PHOSPHORYL-HYDROXY-4 Ν,Ν-DIMETHYLTRYPTAMINE 
16. PSILOCINE: (DIMETHYLAMINO-2ETHYL)-3INDOLOL-4 
17. DMA: 2,5 DIMETHOXYAMPHETAMINE 
18. DOET: 2,5 -DIMETHOXY -4 - ETHYLAMPHETAMINE 
19. CATHINONE: (-)-ALPHA-AMINOPROPIOPHENONE 
20. MMDA: 5-METHOXY -3, 4-METHYLENEDIOXYAMPHETAMINE 
21. MDMA: 3,4 -METHYLENEDIOXYMETHAMPHETAMINE 
22. PMA: PARAMETHOXYAMPHETAMINE 
23. TMA: 3,4, 5- TRIMETHOXYAMPHETAMINE 
24. NABILONE: (±)-TRANS-3-(1-1-DIMETHYLHEPTYL)-6, 6Α, 7, 8,10,10A, HEXAHYDRO-1-
HYDROXY-6, 6-DIMETHYL- 9Η- DIBENZO [Β,Α] PYRAN-9-ONE. 
25. N-HYDROXY MDA: (±) Ν- (ALPHA-METHYL-3,4 
(METHYLENEDIOXY) PHENETHYL) HYDROXYLAMINE 
26.  N-ETHYLMDA:(±)-N-ETHYL-ALPHA-METHYL 3,4(METHYLENEDIOXY) PHENETHYLAMINE 
27.   4-METHYLAMINOREX: (±)- CIS-2 AMINO-4-METHYL-5-PHENYL-2- OXAZOLINE Η (±)- CIS -
4,5 -DIHYDRO -4 METHYL -5- PHENYL-2-OXAZOLAMINE 
28.  BROLAMFETAMINE Η DOB: (+)-4- BROMO-2.5-DIMETHOXY - Α -
METHYLPHENETHYLAMINE 
29.TENAMFETAMINE  OR MDA: Α-METHYL - 3,4 (METHYLENEDIOXY) PHENETHYLAMINE 





32. 4-ΜΕΤΗΟΧΥΜΕΤΗΑΜΡΗΕΤΑΜΙΝΕ. Ρ - ΜΕΤΗΟΧΥ -Ν, A- DIMETHYLPHENETHYLAMINE 
33. METHYLPHENETHYLAMINO) -Α-PHENYLACETONITRILE 
34. PHENATINE: N-(A-METHYLPHENETHYL)NICOTINAMIDE 
35. DIHYDROETORPHINE: 7,8 DIHYDRO - 7 - A - [1- (R) - HYDROXY -1 - METHYL-BUTYL] -6,14 -
ENDO-ETHANOTETRAHYDROORIPAVINE 
36. 4 - MTA: 4 - METHYLTHIOAMPHETAMINE 
37.  METHYL-1-(1,3BENZODIOXOL-5-YL)-2-BUTANAMINE 
38. ETORPHINE, M-99: TETRAHYDRO-(HYDROXY-L-METHYL-BUTYL-1)-7A-ENDOETHENO-
6,14 ORIPAVINE 
39. PMMA Η 4-ΜΜΑ: 4-METHOXYMETHAMPHETAMINE 
40.  GHB: GAMMA-HYDROXYBUTYRIC ACID 
41. 2C-B: 4 - BROMO - 2,5 -DIMETHOXYPHENYLETHYLAMINE 
42. 2C-T-2: 2,5 - DIMETHOXY -4 -ETHYLTHIOPHENETHYLAMINE 
43. 2C-I: 2,5 - DIMETHOXY - 4 - IODO -PHENETHYLAMINE 
44. 2C-T-7: 2,5 -DIMETHOXY-4-(N)-PROPYLTHIOPHENETHYLAMINE  
45. TMA-2: 2,4,5 - TRIMETHOXYAMPHETAMINE 
46. ΒΖΡ: 1-BENZYLPIPERAZINE 
47. TFMPP: 1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE 
48. ΡΜΕΑ: N-ETHYL-4-METHOXYAMPHETAMINE 
49. DOC: 2,5-DIMETHOXY-4-CHLOROAMPHETAMINE 
50. 5-MEO-DMT: 5-METHOXY-N,N-DIMETHYLTRYPTAMINE 
51.  5-MEO-DIPT: 5-METHOXY-DI-ISOPROPYL-TRYPTAMINE 
52.  DPT: N,N-DIPROPYLTRYPTAMINE 
53.  A-MT: ALPHA-METHYLTRYPTAMINE 
54. ALEPH-7: 2,5-DIMETHOXY-4-(N)PROPYLTHIOAMPHETAMINE 
55. 2C-E: 2,5-DIMETHOXY-4-ETHYLPHENETHYLAMINE 
56. 5-MEO-AMT: 5-METHOXY-ALPHAMETHYLTRYPTAMINE 
57. CPP: 1(-3-CHLOROPHENYL) PIPERAZINE 
58. 4-ACO-DET: 4-ACETOXY-N, N-DIETHYLTRYPTAMINE 
59. 2C-D: 4-METHYL-2,5-DIMETHOXYPHENETHYLAMINE 
60. SALTS AND ISOMERS, UNLESS IS SPECIFIED OTHERWISE IN OTHER PROVISION.  
 
TABLE B’ 
1.  ETHYLMORPHINE : ETHYL -3 MORPHINE 
2.  DEXTROMORAMIDE: (+) [METHYL-2-OXO-4 DIPHENYL -3,   3 (PYRROLIDINYL-1) -4 BUTYL] 
- 4MORPHOLINE 
3.  COCAINE: ESTER METHYLIQUE DE LABENZOYLECGONINE 
4.  3 METHADONE: DIPHENYL -4, 4DIMETHYLAMINO  6 HEPTANONE -3 
5. MORPHINE 
6. OPIUM 
7.OPIUM CONCENTRATUM: MELANGE DES BROMHYDRATES DES ALCALOLDES DE L' OPIUM  





9. TETRAHYDROCANNABINOL: PENTYL-3 TETRAHYDRO-6A, 7, 10,  TRIMETHYL-
6,6,9 DIBENZO-6H(B,D) PYRANOL-1 
10. ACETYLMETHADOL:ACETOXY -3 DIMETHYLAMINO -6 DIPHENYL-4, 4 HEPTANE 
11. ALPHACETYLMETHADOL: ALPHA - ACETOXY -3 DIMETHYL - ΑΜΙΝΟ - 6 DIPHENYL - 4, 
4 HEPTANE 
12. DRONABINOL:DELTA-9-TETRAHYDROCANNABINOL 
13. SALTS AND ISOMERS, UNLESS IS SPECIFIED OTHERWISE IN OTHER PROVISION.  
 
TABLE C’ 
1. ETHYLMETHYLTHIAMBUTENE: ETHYLMETHYLAMINO-3 DL- (THIENYL-2') -1,1 BUTENE-1 
2. ACETORPHINE: ACETYL -3-0 TETRAHYDRO -(HYDROXY -1 METHYL -BUTYL- 1) -
7Α ENDOETHENO -6, 14 ORIPAVINE 
3. ACETYLDIHYDROCODEINE 
4. ALPHAMETHADOL:ALPHA-DIMETHYLAMINO-6 DIPHENYL-4, 4 HEPTANOL -3 
5. ALPHA-ETHYL -3 METHYL -1 PHENYL -4 PROPIONOXY-4 PIPERIDINE 
6. ALPHA- DIMETHYL -1, 3 PHENYL -4 PROPIONOXY -4 PIPERIDINE 
7. ALFENTANYL: N-[L-2(4-ETHYL-4,5-DIHYDRO-5-OXO-1H  TETRAZOL-1-YL) ETHYL] 4- 
(METHOXYMETHYL) -4- PIPERIDINYL] N- PHENYLPROPANAMIDE MONOHYDROCHLORIDE 
8. ALLYL -3 METHYL -1 PHENYL -4 PROPIONOXY -4 PIPERIDINE 
9. AMPHETAMINE: Α - METHYLPHENETHYLAMINE 
10. ESTER ETHYLIQUE DE L'ACIDE Ρ - AMINOPHENETHYL  1 PHENYL –A PIPERIDINE -
 CARBOXYLIQUE -4 
11. BEZITRAMIDE: (CYANO -3 DIPHENYL -3,3 PROPYLO) -1 (ΟΧΟ -2 PROPIONYL -
3 BENZIMIDAZOLINYL-1) -4 PIPERIDINE 
12. ESTER ETHYLIQUE DE L'ACIDE (BENZYLOXY -2 ETHYL) 1 PHENYL -4 PIPERIDINE -
CARBOXYLIQUE -4 
13. BENZYL MORPHINE: BENZYL -3 MORPHINE 
14. BETACETYLMETHADOL: BETA-ACETOXY -3 DIMETHYLAMINO -6 DIPHENYL -4, 4 HEPTANE 
15. BETAMETHADOL:BETA-DIMETHYLAMINO-6 DIPHENYL-4, 4 HEPTANOL-3 
16. BETAMEPRODINE: BETA-ETHYL-3 METHYL-1 PHENYL-4 PROPIONOXY-4 PIPERIDINE 
17. BETAPRODINE: BETA-DIMETHYL -1, 3 PHENYL -4 PROPIONOXY -4 PIPERIDINE 
18. CYCLOBUTYLOMETHYLO -3, 14 DIHYDROXY-MORPHINANE 
19. BUTYRATE DE DIOXAPHETYL: MORPHOLINO -4 DIPHENYL -2, 2 BUTYRATE D' ETHYLE 
20. DEXAMPHETAMINE: (+) -Α- METHYLPHENETHYLAMINE 
21. DEXTROPROPOXYPHENE: Α(0) - 4 - DIMETHYLAMINO - 3 -METHYL -1, 2 DIPHENYL-2 
BUTANOL PROPIONATE 
22. DIETHYLTHIAMBUTENE: DIETHYLAMINO -3 DL -(THIENYL -2') -1, 1 BUTENE -1 
23. DIAMPROMIDE: [(N-METHYLPHENETHYLAMINO)-2 PROPYL] PROPIONANILIDE 
24. DIMEPHEPTANOL: DIMETHYLAMINO-6 DIPHENYL-4,4 HEPTANOL-3 
25. DIMETHYLTHIAMBUTENE: DIMETHYLAMINO-3 DI-(THIENYL-2')-1, 1   BUTENE-1 
26. DIMENOXADOL: ETHOXY-1 DIPHENYL-1, 1 ACETATE DE DIMETHYLAMINO- 2 ETHYLE 
27. DIPIPANONE: DIPHENYL-4, 4 PIPERIDINE-6 ΗΕΡΤΑΝΟΝΕ-3 
28. DIHYDROCODEINE: HYDROXY-6 METHOXY-3 N-METHYL-EPOXY- 4, 5 MORPHINANE 




30. DIPHENOXINE: ACIDE 1-(3-CYANO-3, 3 DIPHENYL-PROPYL)-4-PHENYL -4 -
 PIPERIDINECARBOXYLIQUE 
31. DIPHENOXYLATE: ESTER ETHYLIQUE DE L'ACIDE (CYANO-3 DIPHENYL-3, 3 PROPYL)-
1 PHENYL-4PIPERIDINE-CARBOXYLIQUE 4 
32. DROTEBANOL: (3,4 DIMETHOXY-17-METHYLMORPHINAN-6B, 14DIOL) 
33.  ECGONINE: LES ESTERES ET DERIVES SUSCEPTIBLES D'ETRE TRANSFORMES EN 
ECGONINEET COCAINE 
34. COCA (FEUILLES DE COCA) 
35. ETONITAZENE: (DIETHYLAMINO- 2 ETHYL)-1P-ETHOXYBENZYL-2 
NITROBENZIMIDAZOLE-5 
36. ETOXERIDINE: ESTER ETHYLIQUE DE L'ACIDE [(HYDROXY-2 ETHOXY)-2 ETHYL] -1 
PHENYL-4 PIPERIDINE- CARBOXYLIQUE-4 
37. ΤΗΕΒΑΪΝΕ 
38. THEBACONE : ACETYLDIHYDROCODEL'NONE 
39. ISOMETHADONE: DIMETHYLAMINO-6 METHYL-5 DIPHENYL-4,4 HEXANONE-3 
40. ΒΕΝΖΙΜΙΔΑΖΟΛΙΟCLONITAZENE: (P-CHLOROBENZYL)-2 DIETHYLAMINOETHYL-1 NITRO-
5 BENZIMIDAZOLE 
41. CODOXIME: DIHYDROCODEINONE-CARBOXYMETHYLOXIME-6 
42.. LEVOMETHORHANE: (-)-METHOXY-S Ν- METHYLMORPHINANE 
43. LEVOMORAMIDE: (-)-[METHYL-2 OXO-4 DIPHENYL-3, 3 (PYRROLIDINYL -1) -4 BUTYLJ-
4MORPHOLINE 
44. LEVORPHANOL:(-)-HYDROXY-3N-METHYLMORPHINANE 
45. LEVOPHENACYLMORPHANE: (-)-HYDROXY-3N-PHENACYLMORPHINANE 
46. METHADONE INTERMEDIATE: CYANO-4 DIMETHYLAMINO-2 DIPHENYL-4, 4 BUTANE 
47. METHAQUALON:METHYL-2(O-TOLYL)-3QUINAZOLONE-4 
48. METHYLDESORPHINE:METHYL-6-D6-DESOXYMORPHINE 
49. METHYLDIHYDROMORPHINE: METHYL-6 DIHYDROMORPHINE 
50. ΜΕΤΗΑΜΡΗΕΤΑΜΙΝΕ: (+) -Ν,Α- DIMETHYLPHENETHYLAMINE 
51. METHYLPHENIDATE: ESTER METHYLIQUE DE L' ACIDE A-PHENYL-PIPERIDINE-2 
ACETIQUE 
52. MECLOQUALONE : 3-(O- CHLOROPHENYL) - 2- METHYL-4 (3H) QUINAZOLINONE 
53. METAZOCINE : HYDROXY-2' TRIMETHYL-2,5,9 BENZOMORPHANE -6, 7 
54. METOPON: METHYL-5 DIHYDROMORPHINONE 
55. MORAMIDE INTERMEDIATE: ACIDE METHYL-2 MORPHOLINO-3 DIPHENYL-1, 
1 PROPANECARBOXYLIQUE 
56. MORPHERIDINE: ESTER ETHYLIQUE DE L'ACIDE (MORPHOLINO-2 ETHYL)-1 PHENYL-
4 PIPERIDINECARBOXYLIQUE-4 
57. BROMOMETHYLATE DE MORPHINE ET AUTRES DERIVES MORPHINIQUES A AZOTE QUATE
RNAIRE 
58. MYROPHINE: MYRISTYLBENZYLMORPHINE 
59. NICODICODINE: NICOTINYL-6 DIHYDROCODEINE 
60. NICOCODINE: NICOTINYL-6 CODEINE 
61. NICOMORPHINE: DINICOTINYL-3, 6 MORPHINE 






64. NORLEVORPHANOL: (-) - HYDROXY -3MORPHINANE 
65. 3 NORMETHADONE: DIMETHYLAMINO -6DIPHENYL -4, 4 HEXANONE -3 
66. NORMORPHINE: DEMETHYLMORPHINE 
67.  NORPIPANONE: DIPHENYL-4, 4PIPERIDINO-6 HEXANONE-3 
68.  OXYCODONE: HYDROXY-14 DIHYDROCODEINONE 
69.  N-OXYMORPHINE: MORPHINE-N-OXIDE 
70.  OXYMORPHONE: HYDROXY-14 DIHYDROMORPHINONE 
71.  PETHIDINE INTERMEDIAIRE A:CYANO-4 METHYL -1 PHENYL -4 PIPERIDINE 
72.  PETHIDINEINTERMEDIAIRE Β: PHENYL -4 PIPERIDINE - CARBOXYLATE -4 D' ETHYLE. 
73. PETHIDINE INTERMEDIAIRE C: ACIDE METHYLPHENYL-4 PIPERIDINE- CARBOXYLIQUE -4 
74. PENTAZOCINE:DIMETHYLALLYL- 2 DIMETHYL -5,9 HYDROXY - 2'   BENZOMORPHANE 
75. PIMINODINE: ESTER ETHYLIQUE DE L' ACIDE PHENYL -4 (PHENYLAMINO -3 PROPYL) -
1 PIPERIDINE-CARBOXYLIQUE -4 
76. PIRITRAMIDE OU PIRINITRAMIDE : (CYANO-3 DIPHENYL -3, 3 PROPYL) -1 (PIPERIDINE -1)-
4   PIPERIDINE-4-CARBOXAMIDE 
77. PROHEPTAZINE:DIMETHYL-1, 3 PHENYL-4 PROPIONOXY-4 AZACYCLOHEPTANE 
78. PROPERIDINE :ESTER ISOPROPYLIQUE DE L'ACIDE METHYL-1 PHENYLPIPERIDINE -
4 CARBOXYLIQUE-4 
79. PROPIRANE: (N(1-METHYL -2 PIPERIDINOETHYL) -Ν -2 PYRIDYLPROPIONAMIDE 
80. RACEMETHORPHANE: (±) - ΜΕΤΗΟΧΥ-3 Ν- METHYLMORPHINANE 
81. RACEMORAMIDE: (±) - [METHYL -2 ΟΧΟ -4 DIPHENYL -3, 3 (PYRROLIDINYL -1) - 
4 BUTYL]MORPHOLINE 
82. RACEMORPHANE:(±)-HYDROXY-3N-METHYLMORPHINANE 
83. SULFENTANYL: N-[4-(METHOXYMETHYL)-1-[2-(2 THIENYL) ETHYL] -
4 PIPERIDYL] PROPIONANILIDE 
84. ΤΗTILIDINE: (+) - ETHYL -TRANS-2-(DIMETHYLAMINO)-1- PHENYL -3 CYCLOHEXENE -1-
CARBOXYLATE 
85. TRIMEPERIDINE:TRIMETHYL -1,2,5 PHENYL -4 PROPIONOXY -4 PIPERIDINE 
86. HYDROCODONE: DIHYDROCODEINONE 
87.  HYDROMORPHINOL: HYDROXY-14 DIHYDROMORPHINE 
88. HYDROMORPHONE: DIHYDROMORPHINONE 
89.HYDROXYPETHIDINE: ESTER ETHYLIQUE DE L'ACIDE M HYDROXYPHENYL -4 METHYL-
1PIPERIDINE-CARBOXYLIQUE -4 
90. PHENADOXONE: MORPHOLINO-6DIPHENYL -4,4 HEPTANONE -3 
91. PHENAZOCINE: HYDROXY -2' DIMETHYL- 5,9 PHENETHYL-2 BENZOMORPHANE -6,7 
92. PHENAMPROMIDE: Ν- (METHYL-1 PIPERIDINO-2 ETHYL) PROPIONANILIDE 
93. PHENCYCLIDINE: (PHENYL-1CYCLOHEXYL)-1 PIPERIDINE 
94. PHENMETRAZINE: METHYL -3 PHENYL-2MORPHOLINE 
95.  PHENOMORPHANE: HYDROXY-3 Ν-PHENETHYLMORPHINANE 
96. PHENOPERIDINE: ESTER ETHYLIQUE DE L'ACIDE (HYDROXY -3 PHENYL -3 PROPYL) -
1 PHENYL -4PIPERIDINE -CARBOXYLIQUE-4 
97. PHENTANYL: Ν - (PHENETHYL -1 PIPERIDYL -4) PROPIONANILIDE 




99.FURETHIDINE: ESTER ETHYLIQUE DE L'ACIDE (TETRAHYDROFURFURYLO-OXYETHYL-2) -
1 PHENYL-4PIPERIDINE-CARBOXYLIQUE 4 
100. LEVAMPHETAMINE:L-ALPHA-METHYLPHENETHYLAMINE 
101. LEVOMETHAMPHETAMINE:L-N,ALPHA DIMETHYLPHENETHYLAMINE 






105. 3-METHYLFENTANYL N-(3-METHYL-1 -PHENETHYL-4-PIPERIDYL) PROPIONANILIDE 
106. ΜΡΡΡ PROPIONATE (ESTER) DE METHYL-1 PHENYL-4 PIPERIDINOL-4 
107. PEPAP ACETATE (ESTER) DE PHENETHYL-1 PHENYL-4 PIPERIDINOL-4 
108. RACEMATE DEMETAMPHETAMINE (±-N, A-DIMETHYLPHENETYLAMIN 
109. SΕCΟΒΑΡΒΙΤAL 
110. CODEINE: ETHER METHYLIQUE DE LA MORPHINE 
111. ALPHA-METHYLTHIOFENTANYL N-[1[1-METHYL-2-(2-THIENYL)ETHYL]-4-
PIPERIDYL]PROPIONANILIDE 
112. PARA-FLUOROFENTANYL 4-FLUORO-N-(1-PHENETHYL-4-PIPERIDYL)-PROPIONANILIDE 








118. CHLORPHENTERMINE: 4-CHLORO -A, A-DIMETHYLPHENETHYLAMINE 
119. CLOBENZOREX: Ν -(2 -CHLOROBENZYL) -A -METHYLPHENETHYLAMINE 
120. CLOFOREX: ETHYL -(Ρ -CHLORO -A, A DIMETHYLPHENETHYL)    CARBAMATE 
121. CLORTERMINE: 2 -CHLORO -A, A  DIMETHYLPHENETHYLAMINE 
122.   FENBUTRAZATE: 2-(3-METHYL-2-PHENYLMORPHOLINO) ETHYL 2-PHENYLBUTYRATE 
123 PROPYLHEXEDRINE: 2-CYCLOHEXYL-N,1 DIMETHYLETHYLAMINE 
124.  ZIPEPROL: 1-ΜΕΤΗΟΧΥ -3 -[4 -(Β-METHOXYPHENETHYL) - PIPERAZIN- 1 -YL] - 
1 PHENYLPROPAN - 2 - OL 
125. REMIFENTANIL:3-4-CARBOXYL-4-(N-PHENYLPROPIONAMIDE)-L-
PIPERIDINE PROPIONIC ACIDDIMETHYLESTER MONOHYDRATE 
126. TRAMADOL:2-[(DIMETHYLAMINO)METHYL]-1-(3-METHOXYPHENYL)   CYCLOEXANOL 
127.  MEDETOMIDINE:(+/-)-4-(ALPHA,2,3-TRIMETHYLBENZYL)IMIDAZOLE 
128. ATIPAMEZOLE: 4-(2-ETHYL-2,3-DIHYDRO-1 H-INDEN-2-YL)-1 H-IMIDAZOLE 
129. ROMIFIDINE: 2-BROMO-6-FLUORO-2-IMIDAZOLIDINYLIDENEBENZAMINE 
130. ΚΕΤΑΜΙΝΕ: 2 - (2 -CHLOROPHENYL) -2 - (METHYLAMINO) - CYCLOHEXANONE 
131. NALBUPHINE: 17-CYCIOBUTYLMETHYL- 7,8-DIHYDRO-14-HYDROXY-17-NORMORPHINE 
132.  7-[(10,11-DIHYDRO-5HDIBENZO[A,D]CYCLOHEPTEN-5-YL)AMINO] HEPTANOIC ACID 




134. SALTS AND ISOMERS, UNLESS IS SPECIFIED OTHERWISE IN OTHER PROVISION.  
  
TABLE D’ 
1. ETHINAMATE:CARBAMATE D' ETHINYL-1 CYCLOHEXYLE 
2. ETHYL LOFLAZEPATE: ETHYL 7 -CHLORO-5- (O-FLUOROPHENYL) -2,3 -DIHYDRO -2 -OXO-
1H-1.4-BENZODIAZEPINE -3 -CARBOXYLATE 
3. ETHCHLORVYNOL:ETHYL-B-CHLOROVINYL-ETHINYL CARBINOL 
4. HALAZEPAM: 7 -CHLORO-1, 3-DIHYDRO-5-PHENYL -1-(2,2,2- TRIFLUORO-ETHYL)-2H-1,4-
BENZODIAZEPIN -2 -ONE 
5.  HALOXAZOLAM: 10-BROMO-11B (O-FLUOROPHENYL)-2,3,7, 11Β-
TETRAHYDROOXAZOLO [3,2-D] [1,4]-BENZODIAZEPIN-6(5H )-ONE 
6. ALPRAZOLAM: 8 CHLORO -1- METHYL -6- PHENYL -4 Η- S-TRIAZOLO [4,3-Α] 
[1,4] BENZODIAZEPINE 
7.  AMOBARBITAL: ACIDEETHYL -5 (METHYL-3 BUTYL)-5 BARBITURIQUE 
8.  AMPHEPRAMONE: DIETHYLAMINO-2PROPIOPHENONE 
9.  BARBITAL: ACIDE DIETHYL -5, 5 BARBITURIQUE 
10.  BENZPHETAMINE: N-BENZYL-N,A-DIMETHYLPHENETHYLAMINE 
11. BUPRENORPHINE: Ν - CYCLOPROPYL-METHYL-7A (L-(S)-HYDROXY-1,2,2-
TRIMETHYLPROPYL)-6,14ENDOETHANO -6,7,8,14 TETRAHYDRO - NORORIPAVINE 
12. BROMAZEPAM: 7- BROMO -1,3 -DIHYDRO -5-(2-PYRIDYL) -2Η -1,4 -BENZODIAZEPIN -2-ONE 
13. GLUTETHIMIDE: ETHYL -2 PHENYL -2GLUTARIMIDE 
14. DEXTROMETHORPHANE: D-METHOXY-3N-METHYLMORPHINANE 
15. DELORAZEPAM: 7- CHLORO-5- (O-CHLOROPHENYL)-1,3- DIHYDRO -2Η-1.4 -
BENZODIAZEPIN-2-ONE 
16. DIAZEPAM: 7-CHLORO -1,3 - DIHYDRO -1 -METHYL-5-PHENYL-2H - 1,4 - BENZODIAZEPIN -
2- ONE 
17.  ESTAZOLAM: 8 -CHLORO -6 - PHENYL -4Η -5-TRIAZOLO [4,3-Α] [1,4] BENZODIAZEPINE 
18. CAMAZEPAM: 7 -CHLORO -1,3 - DIHYDRO -3-HYDROXY -1-METHYL -5 PHENYL -2Η -1,4-
BENZODIAZEPIN - 2 - ONE DIMETHYLCARBAMATE (ESTER) 
19. KETAZOLAM: 11 -CHLORO -8, 12Β -DIHYDRO-2,8 - DIMETHYL -12Β - PHENYL -4Η -[I,3]-
OXAZINO-[3,2-D][L,4]-BENZODIAZEPINE-4,7 (6H) -DIONE 
20. CLOBAZAM: 7-CHLORO-1-METHYL -5-PHENYL-1H-I.5 - BENZODIAZEPINE -2,4 
(3H,5H) DIONE 
21. CLONAZEPAM: 5- (O-CHLOROPHENYL) -1,3-DIHYDRO -7 -NITRO 2H -1,4 -BENZODIAZEPIN-
2-ONE 
22.  CLOXAZOLAM: 10-CHLORO-11Β - (O-CHLOROPHENYL) -2, 3, 7, 11Β TETRAHYDRO -
OXAZOLO-[3,2-D] [1,4] BENZODIAZEPIN -6 - (5Η) - ONE 
23. CLOTIAZEPAM: 5-(O -CHLOROPHENYL) -7- ETHYL-1,3 - DIHYDRO -1 - METHYL -2Η- ΤΗΙΕΝΟ 
[2,3-Ε] [1,4] DIAZEPIN-2-ONE 
24. CYCLOBARBITAL: ACIDE(CYCLOEXENE-1YL-1)-5 ETHYL -5 BARBITURIQUE 
25. MAZINDOL: 5- (P-CHLOROPHENYL)-2,5- DIHYDRO-3H-IMIDAZO (2,1-A)-ISOINDOL-5-OL 
26. LOPRAZOLAM:6-(O-CHLOROPHENYL)-2,4-DIHYDRO-2-[(4-METHYL-1-








29. MEDAZEPAM: 7-CHLORO-2,3-DIHYDRO-1-METHYL-5- PHENYL-1 H -1,4-BENZODIAZEPINE 
30. METHYLPHENOBARBITAL: ACIDE METHYL-1 ETHYL-5 PHENYL-5 BARBITURIQUE 
31. METHYPRYLON: DIETHYL-3,3DIOXO-2,4 METHYL-5 PIPERIDINE 
32. MEPROBAMATE:BICARBAMATE DE METHYL-2 PROPYL-2 PROPANEDIOL-1.3 
33. METAZEPAM: 1,3 DIHYDRO-1-METHYL-7-NITRO-5-PHENYL-2Η-1.4 BENZODIAZEPIN-2-ΟΝΕ 
34.  ΒΕΝΖΟΔΙΑΖΕΠΙΝ -2-ΟΝΗ NITRAZEPAM: 1,3 -DIHYDRO-7-NITRO-5-PHENYL -2Η -
1,4 BENZODIAZEPIN -2 -ΟΝΕ 
35. NORDAZEPAM: 7-CHLORO-1,3-DIHYDRO-5-PHENYL -2 Η -1,4- BENZODIAZEPIN -2 -ΟΝΕ 
36.  ΟΧΑΖΕΡΑΜ: 7-CHLORO-1.3-DIHYDRO-3-HYDROXY-5-PHENYL-2H -1,4-BENZODIAZEPIN - 2-
ΟΝΕ 
37. OXAZOLAM: 10-CHLORO- 2, 3, 7, 11Β- TETRAHYDRO- 2 METHYL -1 ΙΒ-
PHENYLOXAZOLO (3,2-D) (1,4) BENZODIAZEPIN -6(5H )-ONE 
38.   PENTOBARBITAL: ACIDEETHYL-5 (METHYL-1 BUTYL) 5 BARBITURIQUE 
39. ΡΙΝΑΖΕΡΑΜ: 7-CHLORO-1,3-DIHYDRO-5-PHENYL-1-(2-PROPYNYL) -2Η-1.4-
BENZODIAZEPIN -2-ΟΝΕ 
40. DIPHENYL-1,1 (PIPERIDYL-2)-1 METHANOL 
41. PRAZEPAM: 7-CHLORO-1-(CYCLOPROPYLMETHYL)-1,3- DLHYDRO-5-PHENYL-2H-1,4-
BENZODIAZEPIN-2-ONE 
42.  SPA: (-)-DIMETHYLAMINO-L DIPHENYL-1,2 ETHANE 
43. PHENDIMETRAZINE: (+)-3,4-DIMETHYL-2-PHENYLMORPHOLINE 




46. TRIAZOLAM: 8-CHLORO-6-(O-CHLOROPHENYL)-1-METHYL-4H-S-TRIAZOLO [4,3-Α] 
[1,4]BENZODIAZEPINE 








52. CHLORAZEPATE: 7-CHLORO-2.3-DIHYDRO-2-OXO-5-PHENYL-1 Η-1,4-BENZODIAZEPINE-3-
CARBOXYLIQUE ACIDE 
53. CHLORODIAZEPOXIDE: 7-CHLORO-2-(METHYLAMINO)-5- PHENYL-3H-1,4-
BENZODIAZEPINE-4-OXIDE 
54. ALLOBARBITAL : ACIDE DIALLYL-5,5BARBITURIQUE 
55. VINYLBITAL: ACIDE(METHYL-1 BUTYL)-5 VINYL-5 BARBITURIQUE 




57.  BUTOBARBITAL: ACIDE BUTYL- 5ETHYL- 5 BARBITURIQUE 
58. CATHINE: D-THREO-2-AMINO-L-HYDROXY-L-PHENYL PROPANE 
59. MEFENOREX: DL-N -(3-CHLOROPROPYL) -ALPHA METHYLPHENETHYLAMINE 
60. PYROVALERONE:DL-L-(4-METHYLPHENYL)-2-(1-PYRROLIDINYL)-1-PENTANONE 
62. SECOBARBITAL: ACIDE SEC-BUTYL-5 ETHYL-5 BARBITURIQUE 
63. FENCAMFAMIN: DL-N-ETHYL-3-PHENYLBICYCLO (2,2,Ι)-ΗΕΡΤΑΝ -2 -ΑΜΙΝΕ 
64. FENPROPOREX: DL- 3- [(ALPHA -METHYLPHENETHYL) ΑΜΙΝΟ]-PROPIONITRILE  
65. BROTIZOLAM: 2- BROMO-4- (2-CHLOROPHENYL) -9-METHYL-6H-THIENO [3,2-F] 
[1,2,4] TRIAZOLO-[4, 3-A] 
[1, 4] DIAZEPIN  
66. PEMOLINE: 2-AMINO-5-PHENYL-2-OXAZOLIN-4-ONE  
67. MIDAZOLAM: 8-CHLORO-6-(O-FLUOROPHENYL)-1-METHYL-4H-IMIDAZO(1,5-Α) (1,4) 
BENZODIAZEPINE 
68. QUAZEPAM: 7-CHLORO-5-(2-FLUOROPHENYL)-1,3-DIHYDRO-1-(2, 2, 2,-TRIFLUOROETHYL)-
2H-1,4-BENZODIAZEPINE-2-THIONE 
69. THIOPENTAL: 5-ETHYL-5-(1-METHYLBUTYL)-2 THIOBARBITURIC ACID 
70.PROXIBARBAL: 5-(2-HYDROXYPROPYL)-5-(2-PROPENYL)-2, 4, 6 (1Η, 3Η, 5Η)-
PYRIMIDINETRIONE. 5-ALLYL-5-(2 HYDROXYPROPYL) BARBITURIC ACID. 
71. MESOCARB: 3-(A-METHYLPHENETHYL)-N- PHENYLCARBAMOYL) SYNDONE (MINE 
72. MODAFINIL: 2-[(DIPHENYLMETHYL) SYLFINYL] ACETAMIDE 
73. ZOLAZEPAM: 4 - (Ο- FLUOROPHENYL) 6,8- DIHYDRO 1,3,8 - TRIMETHYLPYRAZOLO [3,4-E] 
[1,4] -DIAZEPIN 7 (1 H)-ONE 
74. ZALEPLON: N-[3-(3-CYANOPYRAZOLO[1,5-A] PYRIMIDIN-7-YL)PHENYL]-N-
ETHYLACETAMIDE 
75. ZOLPIDEM: N,N,6-TRIMETHYL-2-(4 METHYLPHENYL) IMIDAZO(1,2-A) PYRIDINE-3-
ACETAMIDE 
76. ZOPICLONE: 6-(5-CHLOROPYRID-2-YL)-5-(4-METHYLPIPERAZIN-1 -YL) CARBONYLOXY-7-
OXO-6, 7-DIHYDRO5H-PYRROLO- [3,4-B] PYRAZINE 





10.2 TYPES OF MEDICAL PRESCRIPTIONS 
 
 
Figure 1. Medical prescription model from a private doctor [40] 
 
 






Figure 3. Model of a hospital prescription [38] 
 
 

















Figure 7. Medical prescription without a brand name drug [40] 
 
 








MEDICAL PRESCRIPTIONS IN GREECE 
 
Author: Naoum I. Panagiotis 
Tutor: RNDr. Jana Kotlářová, Ph.D. 
Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Kralove, 
Charles University in Prague, Czech Republic   
 
Aim of diploma thesis: 
 The aim of diploma thesis is: to get current knowledge about medical 
prescriptions (MP) in Greece and rules of their use; to prepare its basic division 
according their kinds, formal look, practical handle with them and their payment; to get 
sample of different MP and finally to describe the current Greek health, pension and 
insurance system as a secondary aim. 
Results: 
In this diploma thesis it has been described the existing model of medical 
prescriptions in Greece and have been given adequate information about their basic 
divisions, their kinds, their formal look, and their compensation. Also it is described the 
course of the prescription, from the doctor to the pharmacist, harmonized with modern 
electronic prescribing.  
In the recent years (from 2009), Greece started the pilot implementation of e-
prescribing for the modernization of public administration. This reform was established 
in order to fight against impunity and seemingly anti-ethical actions. The measure was 
certified by the laws of the Greek State, whereas the first results are starting to show up. 
Conclusion: 
Prescription of drugs in Greece is covered and described by certain basic 
therapeutic and legal principles that determine the amount and prevent the emergence of 
practices, such as over prescription. The doctor and the pharmacist are accountable and 
responsible for the proper execution and sponsorship of these prescriptions. Otherwise, 
they are requested by the competent supervisory authorities and if necessary, report to 
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Cíl práce:  
Cílem práce je zpracovat základní materiály související s lékařskými předpisy a 
pravidly jejich používání v Řecku; vytvořit přehled podle jejich druhů, formální 
stránky, praktického zacházení s nimi a jejich úhrady; získat ukázky řeckých lékařských 
předpisů. Dále přiblížit současný řecký zdravotní a sociální systém, včetně zdravotního 
pojištění.  
Výsledky: 
V diplomové práci je popsán současný model lékařských předpisů v Řecku, 
jejich základní rozdělení, druhy, formální úprava a možnosti jejich úhrady. Dále je 
zachycen proces předepisování léčivých přípravků na cestě od lékaře k lékárníkovi, s 
ohledem na moderní elektronickou preskripci. 
V nedávné době (2009) byl v Řecku nastartován projekt implementace 
elektronického předepisování léčivých přípravků přispívající k celkové elektronizaci a 
modernizaci veřejné správy. Tato reforma je obecně realizována za účelem boje proti 
podvodům a neetickému jednání. Nyní jsou již patrné první pozitivní výsledky. 
Závěr: 
Předepisování léčivých přípravků v Řecku je zaštiťováno a popsáno konkrétními 
základními terapeutickými a zákonnými principy, které předcházejí vzniku situací, kdy 
by např. došlo k předepsání jejich nadměrného množství. Lékaři a lékárníci jsou 
zodpovědní za správné předepsání a vydání receptu. Při pochybení jsou pak 
prověřováni příslušným kontrolním úřadem, a pokud je to nezbytné, jsou předáni 
řeckému soudu. 
 
